haloperidol has been researched along with levodopa in 290 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 182 (62.76) | 18.7374 |
1990's | 46 (15.86) | 18.2507 |
2000's | 23 (7.93) | 29.6817 |
2010's | 35 (12.07) | 24.3611 |
2020's | 4 (1.38) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Ahmed, MA; Alkskas, IA; Azam, F | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Bajpai, M; Banerjee, A; Bhateja, DK; Gandhi, MN; Gharat, LA; Gudi, GS; Gullapalli, S; Gupta, PK; Khairatkar-Joshi, N; Patil, S; Pawar, MY; Sangana, RR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Howard, JS | 1 |
Dill, RE; Dorris, RL; Phillips-Thonnard, I | 1 |
Quik, M; Sourkes, TL | 1 |
Carroll, BJ; Curtis, GC; Kokmen, E | 1 |
McGilliard, KL; Takemori, AE | 1 |
Monti, JM | 1 |
Carvey, PM; Klawans, HL; Nausieda, PA; Weiner, WJ | 1 |
Desiles, M; Puech, AJ; Rips, R | 1 |
Colantino, M; Herzog, J; Resch, G; Sowers, JR; Tempel, G | 1 |
Ferin, M; Langer, G; Sachar, EJ | 1 |
Crossman, AR; Sambrook, MA; Slater, P | 1 |
Mato, M; Ookawara, S | 1 |
Anisman, H; Remington, G; Sklar, LS | 1 |
Anisman, H; Irwin, J; Sklar, LS | 1 |
Schmidt, WJ | 2 |
Akil, H; Liebeskind, JC | 1 |
Gershon, S; Hine, B; Wallach, MB | 1 |
Tolosa, ES | 1 |
Darwish, SA; Furman, BL | 1 |
Jahodová, J; Pribyl, T; Schreiber, V | 1 |
Arushanian, EB; Avakian, RM | 2 |
Calne, DB; Eisler, T | 1 |
Korf, J; Sebens, JB | 1 |
Eidelberg, E; Erspamer, R | 1 |
Battista, AF; Goldstein, M; Miyamoto, T | 1 |
Bernheim-Chatelain, C; Ecoffet, M; Gilbert, JC; Jaillon, P; Willer, JC | 1 |
Carolei, A; Margotta, V; Palladini, G | 1 |
Myslinski, NR; Thut, PD | 1 |
Furuta, Y; Hashimoto, K; Washizaki, M | 1 |
Marais, C | 1 |
Jacob, JJ; Ramabadran, K | 1 |
Lazarova, MB; Roussinov, KS | 2 |
Georgiev, VP; Markovska, VL; Petkova, BP | 1 |
Fukuyama, Y; Hayakawa, T; Miyagawa, F; Ochiai, Y | 1 |
Bogaert, MG; Willems, JL | 1 |
Honda, F; Mori, J; Satoh, H; Satoh, Y | 1 |
van Rossum, JM | 1 |
Godwin-Austen, RB | 1 |
Lai, C; Tolosa, ES | 1 |
Anlezark, GM; Marsden, CD; Meldrum, BS | 1 |
Baldini, A; Ciottoli, GB; Lisciani, R | 1 |
Arushanian, EB; Avakian, RM; Kozlov, VKh; Pergaev, AP | 1 |
List, SJ; Seeman, P | 1 |
Bednarczyk, B; Podolec, Z; Szczeklik, A; Vetulani, J | 1 |
Bellodi, L; Brambilla, F; Malagoli, G; Negri, F; Smeraldi, E | 1 |
Dadkar, VN; Dahanukar, SA; Sheth, UK | 1 |
Adlmici, G; Callea, L; Di Monda, V; Fazzari, G | 1 |
Kisara, K; Sakurada, S; Shoji, T | 1 |
Martin, JR; Quock, RM | 1 |
Uemura, H | 1 |
Rektor, I | 1 |
Johnels, B; Steg, G; Ungerstedt, U | 1 |
Bradford, HF; De Belleroche, J | 1 |
Farley, IJ; Hornykiewicz, O; Lee, T; Rajput, A; Seeman, P | 1 |
Lewis, PR; Miller, JW; Seybold, VS | 1 |
Loizzo, A; Longo, VG; Mora, S | 1 |
Battista, AF; Goldstein, M; Matsumoto, Y; Miyamoto, T | 1 |
Glick, SD; Jerussi, TP | 1 |
Bonnet, K; Friedhoff, AJ; Tosengarten, H | 1 |
Bartolini, A; Mantovani, P; Pepeu, G | 1 |
Clouet, DH; Iwatsubo, K | 1 |
Baudry, M; Martres, MP; Schwartz, JC | 1 |
Hornykiewics, O; Lloyd, KG | 1 |
Blum, K; Eubanks, JD; Schwertner, HA; Wallace, JE | 1 |
Avakian, RM | 1 |
Korobov, NV; Uspenskiĭ, AE | 1 |
Debono, AG; Marsden, CD; Parkes, JD | 1 |
Kimura, Y; Kisaki, N; Sakurada, S; Tadano, T | 1 |
Gräf, HJ; Horowski, R | 1 |
Fielding, S; Lal, H; Marky, M | 1 |
Knopp, W; Messiha, FS | 1 |
Costall, B; Naylor, RJ | 1 |
Boucher, R; Dankova, J; Poirier, LJ | 1 |
Colpaert, FC; Laduron, P; Lal, H | 1 |
Sparber, SB; Takemori, AE; Tulunay, FC | 1 |
Capone, D; Ombrato, M | 1 |
Fukushima, N | 1 |
Marsden, CD; Pycock, C; Tarsy, D | 1 |
Fujiwara, M; Ibii, N; Inoue, K; Kataoka, Y; Ueki, S | 1 |
Stimmel, GL | 1 |
Barsegian, GG; Butenko, OB; Kordzadze, RN | 1 |
Fredow, G; Löscher, W | 1 |
Dinari, G; Kiro, A; Marcus, H; Zahavi, I | 1 |
Barbanel, G; Kamenka, JM; Maurice, T; Vignon, J | 1 |
Drucker-Colín, R; García-Hernández, F | 1 |
Campbell, N; Evans, C; Franco, K; Pentz, J; Tamburrino, M | 1 |
Joyce, JN; Neal, BS | 1 |
Hotta, K; Mizusawa, H; Morita, S; Nagase, T; Omote, M; Sakai, K; Yamane, M | 1 |
Hata, T; Kawamura, M; Miura, T; Namimatsu, A; Ohara, H; Yoneda, R | 1 |
Abbate, GM; Nieduzak, TR; Schmidt, CJ; Taylor, VL | 1 |
el-Sawaf, HA; Puri, VN; Rao, KV | 1 |
Elazar, Z; Ganchrow, D; Korczyn, AD; Paz, M; Paz, Z; Rabinowitz, R | 1 |
Bartel, P; Becker, P; Blom, M; Robinson, E; Sommers, DK; van der Meyden, C | 1 |
Cohen, G | 1 |
Malyshev, IuI | 1 |
Defazio, G; Ferrari, E; Lamberti, P; Lepore, V; Livrea, P | 1 |
Rammsayer, T | 1 |
Imazu, Y; Kobayashi, K; Shohmori, T | 1 |
Cho, K; Kusunoki, Y; Oki, J; Sasaki, N | 1 |
Igarashi, N; Minami, S; Okabe, T; Sato, T | 1 |
Fujimoto, H; Kawai, H; Masuda, T; Saito, S | 1 |
Jenner, P; Marsden, CD; Rupniak, NM | 1 |
Fowler, CJ; Magnusson, O; Mohringe, B; Ogren, SO; Wijkström, A | 1 |
Kaakkola, S; Männistö, PT; Nuutila, J | 1 |
Caporali, MG; Longo, VG; Ongini, E | 1 |
Heikkila, RE; Manzino, L; Sonsalla, PK | 1 |
Pugsley, TA; Stewart, SF | 1 |
Wambebe, C | 1 |
Basciani, M; Gambi, D; Ghilardi, MF; Onofrj, M | 1 |
Konstantinova, E; Petkov, VD; Petkov, VV; Popova, J | 1 |
Bizière, K; Kan, JP; Roncucci, R; Wermuth, CG; Worms, P | 1 |
Bowman, RE; Levin, ED; Vuchetich, J; Wegert, S | 1 |
Barnes, JC; Barnes, NJ; Barnes, NM; Costall, B; Domeney, AM; Naylor, RJ | 1 |
Mitsuma, T; Nogimori, T | 1 |
Bhalla, S; Mehta, VL; Wafai, ZA | 1 |
Herberg, LJ; Mintz, M; Rose, IC | 1 |
Boyadjieva, M; Ovtcharov, R; Zaharieva, B | 1 |
Hayashi, M; Iwakawa, Y; Kohyama, J; Ogiso, M; Shimohira, M; Suzuki, H | 1 |
Imazu, Y; Kobayashi, K; Shomori, T | 1 |
Geber, J; Gjuris, V; Krizanac, S; Mise, S; Petek, M; Rotkvić, I; Sikirić, P; Suchanek, E; Tućan-Foretić, M; Udovicić, I | 1 |
Harris, M; Nora, L; Tanner, CM | 1 |
Algeri, S; Olgiati, VR; Stramentinoli, G | 1 |
Ahlenius, S; Criborn, CO; Henriksson, C; Hillegaart, V | 1 |
Colpaert, FC | 1 |
Flechter, S; Graff, E; Oberman, Z; Rabey, JM; Vardi, J | 1 |
Corsi-Cabrera, M; Galarraga, E; Sangri, M | 1 |
Cvitanović, B; Geber, J; Gjuris, V; Ivanović, D; Mise, S; Rotkvić, I; Sikirić, P; Suchanek, E; Tućan-Foretić, M | 1 |
Aizenstein, ML; de-Lucia, R; Scavone, C; Steinschreiber, S | 1 |
Cohen, O; Globus, M; Melamed, E; Rosenthal, J; Uzzan, A | 1 |
Jackson, DM; Jenkins, OF | 1 |
Shapovalova, KB | 1 |
Boiadzhieva, N; Ovcharov, R; Zakharieva, B | 1 |
Watanabe, H | 2 |
Baumeister, A; Breese, GR; Frye, GD; Mueller, RA; Napier, TC | 1 |
Poddar, MK; Ray, SK | 1 |
Aleksić, J; Geber, J; Gjuris, V; Ivanović, D; Marović, A; Reić, P; Sikirić, P; Suchanek, E | 1 |
Olson, LG; Saunders, NA | 1 |
Fayle, P; Jackson, DM; Jenkins, OF; Lafferty, PA | 1 |
Grewaal, DS; McGeer, EG; McGeer, PL | 1 |
Bédard, P; Boucher, R; Langelier, P; Larochelle, L; Parent, A; Poirier, LJ; Roberge, AG | 1 |
Poirier, LJ | 1 |
Antonaccio, MJ; Robson, RD | 1 |
Marsden, CD | 1 |
Fawcett, CP; Krulich, L; McCann, SM; Ojeda, SR | 1 |
Anagnoste, B; Battista, AF; Fuxe, K; Goldstein, M; Miyamoto, T | 1 |
Rosin, AJ | 1 |
Chase, TN | 1 |
Kadzielawa, K | 1 |
Grahovska, T; Konstantinova, E; Petkov, VD; Petkov, VV | 2 |
Mine, S | 1 |
Frohman, LA; Maeda, K | 1 |
Klusha, VE; Kozlovskaia, MM; Svirskis, ShV; Val'dman, AV | 1 |
Haubrich, DR; Pflueger, AB | 1 |
Algeri, S; Carolei, A; Ferretti, P; Gallone, C; Palladini, G; Venturini, G | 1 |
Ishibashi, M; Yamaji, T | 1 |
Carvey, P; Goetz, CG; Klawans, HL | 1 |
Luther, JS; Stoudemire, A | 1 |
Itoh, M; Nohtomi, A; Uchimua, H; Yufu, N | 1 |
Galliani, G; Glässer, A; Restelli, A; Rosina, R | 1 |
Abe, H; Chihara, K; Imura, H; Iwasaki, Y; Kato, Y | 1 |
Czuczwar, SJ; Kleinrok, Z; Kozicka, M | 1 |
Chaya, M; Mitsuma, T; Nogimori, T | 1 |
Ambrosoli, C; Armocida, G; Finavera, L; Majeron, MA; Quisi, Q | 1 |
Dvorkin, MA; Medina, JH; Pazo, JH; Tumilasci, OR | 1 |
Osuide, G; Wambebe, C | 1 |
Ortiz, A | 1 |
Halász, B; Nagy, G | 1 |
Arruda, F; Campos, F | 1 |
Bridger, WF; Gardner, EL; Seeger, TF | 1 |
Bannet, J; Belmaker, RH; Globus, M; Lerer, B | 1 |
Georgiev, V; Markovska, V | 1 |
Friedhoff, AJ; Friedman, E; Rosengarten, H | 1 |
Carvey, P; Goetz, CG; Klawans, HL; Nausieda, PA; Weiner, WJ | 2 |
Matsumiya, T; Oka, T; Watanabe, Y | 1 |
Friedhoff, AJ | 1 |
Nomura, Y; Segawa, M | 1 |
Honda, Y; Kagono, Y; Kita, S; Saito, M; Suitsu, N | 1 |
Huot, S; Palfreyman, MG; Wagner, J | 1 |
Fahn, S; Jackson, V; Jiang, D; Reches, A; Wagner, HR | 1 |
Korányi, L; Phelps, CP; Tamásy, V | 2 |
Medina, JH; Pazo, JH; Tumilasci, OR | 1 |
Heffner, TG; Stricker, EM; Zigmond, MJ | 1 |
Lin, MT | 1 |
Hefti, F; Melamed, E | 1 |
Demarest, KT; Moore, KE | 1 |
Clement-Cormier, Y; Smith, CE | 1 |
Lucot, JB; Schuster, CR; Seiden, LS; Wagner, GC | 1 |
Gudelsky, GA; Nansel, DD; Neaves, WB; Porter, JC; Reymond, MJ | 1 |
Golub, M; Sowers, DK; Sowers, JR; Tuck, M | 1 |
Aubry, AF; Ibrahim, H | 1 |
Ghosh, S; Poddar, MK | 1 |
Schmidt, WJ; Zadow, B | 1 |
Nezlin, L; Sakharov, D; Voronezhskaya, E | 1 |
Himori, N; Mishima, K | 1 |
Kanda, T; Nakamura, J; Shimada, J; Shiozaki, S; Suzuki, F | 1 |
Strange, PG | 1 |
Akaike, N; Himori, N; Kurasawa, M; Mishima, K; Tanaka, Y | 1 |
Abou-Rebyeh, F; Bauer, C; Hocher, B | 1 |
Kunihara, M; Nakano, M; Ohyama, M | 1 |
Nantwi, KD; Schoener, EP | 1 |
Hadjiconstantinou, M; Hubble, JP; Neff, NH; Sylvia, CP; Wemlinger, TA | 1 |
Fisher, H; Myers, CS; Wagner, GC | 1 |
Arutiunian, NA; Iakimovskiĭ, AF | 1 |
Bishop, MR; Markopoulou, K; Pavletic, ZS; Wszolek, ZK | 1 |
Barber, A; Bartoszyk, GD; Gottschlich, R; Seyfried, CA | 1 |
Baĭchurina, AZ; Garaev, RS; Semina, II | 1 |
Dobrynina, MT; Dovedova, EL; Gershteĭn, LM; Rakhmanova, VI; Sergutina, AV | 1 |
Cherin, P; Colvez, A; Deville de Periere, G; Sereni, D | 1 |
Kołodziejczyk, K; Maj, J; Rogóz, Z; Skuza, G | 1 |
Araki, T; Itoyama, Y; Kobayashi, T; Ohta, T; Oshima, Y; Takeshita, M | 1 |
Baudewig, J; Bruns, D; Paulus, W; Tergau, F; Ziemann, U | 1 |
de la Fuente-Fernández, R | 1 |
Hashitani, T; Kumazaki, M; Mizukawa, K; Nishino, H | 1 |
Busel, BI; Sanzharovsky, AV; Storozhuk, VM | 1 |
Kachalova, LM; Popova, NS; Ustinovskaia, OV | 1 |
Colado, MI; Esteban, B; Granados, R; Green, AR; Martín, AB; O'Shea, E | 1 |
Danysz, W; Karcz-Kubicha, M; Lorenz, B | 1 |
Khlebnikova, NN; Lutsenko, VK | 1 |
Gainetdinov, R; Huotari, M; Männistö, PT | 1 |
Maj, J; Rogóz, Z; Skuza, G | 1 |
Chambers, LK; Greenamyre, JT; Jaw-Tsai, SS; Menniti, FS; Steece-Collier, K | 1 |
Jenner, P; Rose, S; Treseder, SA | 1 |
Konieczny, J; Lorenc-Koci, E; Wardas, J | 1 |
Chartoff, EH; Dorsa, DM; Marck, BT; Matsumoto, AM; Palmiter, RD | 1 |
Ohye, C; Shibazaki, T | 1 |
Bai, O; Bowen, R; Chlan-Fourney, J; Keegan, D; Li, XM | 1 |
Hillis, RE; Lee, DA | 1 |
Allouard, N; Alonso, R; Brun, P; Claustre, Y; Damoiseau, G; Françon, D; George, P; Gueudet, C; Lourdelet, J; Oblin, A; Peretti, DD; Scatton, B; Schoemaker, H; Sevrin, M; Soubrié, P; Steinberg, R; Suaud-Chagny, MF | 1 |
Carlsson, A; Gefvert, O; Lindström, LH; Tedroff, J; Waters, N; Waters, S | 1 |
Chartoff, EH; Dorsa, DM; Palmiter, RD; Szczypka, MS | 1 |
Brotchie, JM; Fox, SH; Gomez-Ramirez, J; Johnston, TH; Lee, J | 1 |
Cenci, MA; Danysz, W; Dekundy, A; Pietraszek, M; Schaefer, D | 1 |
Borman, JB; Houminer, E; Khaliulin, I; Schneider, A; Schwalb, H | 1 |
Dolan, RJ; Flandin, G; Frith, CD; Pessiglione, M; Seymour, B | 1 |
Archer, T; Fredriksson, A | 1 |
Barodia, SK; Luthra, PM; Raghubir, R | 1 |
Dziubina, A; Gołembiowska, K; Kamińska, K; Kowalska, M | 1 |
Dolan, RJ; Pine, A; Seymour, B; Shiner, T | 1 |
Bateup, HS; Birnbaum, S; Fisone, G; Greengard, P; Nestler, EJ; Santini, E; Shen, W; Surmeier, DJ; Valjent, E | 1 |
Ardashov, OV; Il'ina, IV; Karpova, EV; Korchagina, DV; Morozova, EA; Pavlova, AV; Salakhutdinov, NF; Tolstikova, TG; Volcho, KP | 1 |
Amalric, M; Blobaum, AL; Bode, J; Bridges, TM; Bubser, M; Conn, PJ; Daniels, JS; Dickerson, JW; Engers, DW; Hopkins, CR; Italiano, K; Jadhav, S; Jones, CK; Lindsley, CW; Morrison, RD; Niswender, CM; Thompson, AD; Turle-Lorenzo, N | 1 |
Both, S; Oei, NY; Rombouts, SA; Soeter, RP; van Gerven, JM | 1 |
Bacolod, MD; Bennouar, KE; Cajina, M; Doller, D; Gubellini, P; Jimenez, HN; Kerkerian-Le Goff, L; Melon, C; Uberti, MA | 1 |
Ionov, ID; Severtsev, NN | 1 |
Beckmann, CF; Both, S; Cole, DM; Oei, NY; Rombouts, SA; Soeter, RP; van Gerven, JM | 1 |
Ballaz, S; Fuentes, A; Morales, I; Obeso, JA; Rodriguez, M | 1 |
Andreou, C; Moritz, S; Naber, D; Veckenstedt, R; Veith, K | 1 |
Agulleiro, MJ; Cerdá-Reverter, JM; Conde-Siera, M; Fernández-Durán, B; Leal, E; Míguez, JM | 1 |
Bleickardt, C; Hodgson, R; Jones, N; Mullins, D; Parker, E | 1 |
Andreou, C; Bozikas, VP; Lincoln, TM; Moritz, S; Veith, K | 1 |
Demaro, JA; Gereau, RW; Golden, JP; Hoshi, M; Jain, S; Johnson, EM; Knoten, A; Pehek, E | 1 |
Gelfius, CD; Mortimer, D; Potts, MA | 1 |
Bestmann, S; Galea, JM; Rothwell, J; Ruge, D | 1 |
Danysz, W; Dekundy, A; Hofmann, M; Mela, F | 1 |
Fujita, M; Hagino, Y; Hashimoto, M; Ikeda, K; Kasai, S; Kobayashi, K; Meltzer, HY; Setogawa, S; Yamaura, H; Yanagihara, D | 1 |
Goyal, RK; Jhala, MK; Joshi, CG; Patel, AK; Rana, DG | 1 |
Averbeck, BB; Costa, VD; Tran, VL; Turchi, J | 1 |
Bubser, M; Cenci, MA; Conn, PJ; Hopkins, CR; Iderberg, H; Jones, CK; Lindsley, CW; Maslava, N; Niswender, CM; Thompson, AD | 1 |
Bardin, L; Cenci, MA; Depoortère, R; Iderberg, H; Kleven, MS; Koek, W; McCreary, AC; Newman-Tancredi, A; Varney, MA | 1 |
Andreou, C; Braun, V; Gallinat, J; Kolbeck, K; Moritz, S; Schneider, BC | 1 |
Andreou, C; Kolbeck, K; Moritz, S | 1 |
Golebiowska, J; Rygula, R | 1 |
Fülöp, F; Hashizume, T; Inaba, Y; Nagy, GM; Sawai, K; Watanabe, R | 1 |
Baastrup, C; Benedetti, F; Grosen, K; Hall, KT; Jensen, TS; Kaptchuk, TJ; Moslemi, K; Petersen, GL; Price, DD; Skyt, I; Svensson, P; Vase, L | 1 |
Gupta, S; Patel, RK; Sharma, AK; Wardhan, N | 1 |
Hernaus, D; Mehta, MA; van Ruitenbeek, P | 1 |
Guerrero, MF; López, JL; Olaya, MDP; Vergel, NE; Viña, MD | 1 |
Adekenov, SM; Arystan, LI; Haydargalieva, LS; Muldaeva, GM; Nurmaganbetov, ZS | 1 |
Chakroun, K; Ganzer, F; Mathar, D; Peters, J; Wiehler, A | 1 |
Adekunle, AO; Alananzeh, WA; Amali, MO; Ayipo, YO; Badeggi, UM; Lawal, BA; Mordi, MN | 1 |
Hirschbichler, ST; Manohar, SG; Rothwell, JC | 1 |
Chakroun, K; Ganzer, F; Mathar, D; Peters, J; Sommer, T; van Eimeren, T; Wagner, B; Wiehler, A | 1 |
9 review(s) available for haloperidol and levodopa
Article | Year |
---|---|
The pathogensis and medical treatment of extrapyramidal disease.
Topics: Adult; Athetosis; Basal Ganglia Diseases; Caudate Nucleus; Chorea; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Administration Schedule; Dystonia; Female; gamma-Aminobutyric Acid; Glutamates; Haloperidol; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Tic Disorders | 1979 |
[Duality of dopaminergic receptors. Pharmacologic and clinical perspectives].
Topics: Animals; Apomorphine; Benzamides; Chorea; Fluorescent Antibody Technique; Guinea Pigs; Haloperidol; Humans; Levodopa; Movement Disorders; Parkinson Disease; Rats; Receptors, Dopamine | 1978 |
Two types of dopamine receptors in behavioral regulation.
Topics: Animals; Behavior; Behavior, Animal; Benserazide; Brain; Carbidopa; Cats; Dopamine; Haloperidol; Humans; Levodopa; Psychomotor Agitation; Rats; Receptors, Dopamine; Reserpine; Snails; Tranquilizing Agents | 1978 |
Acute dystonia induced by neuroleptic drugs.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease Models, Animal; Drug Synergism; Dystonia; Fluphenazine; Haloperidol; Histamine H1 Antagonists; Levodopa; Mastication; Methyltyrosines; Movement Disorders; Parasympatholytics; Physostigmine; Primates; Rats | 1986 |
[Possible neurophysiological and neurochemical mechanisms for participation of the striatum in initiating and regulating involuntary movement].
Topics: Afferent Pathways; Animals; Avoidance Learning; Caudate Nucleus; Corpus Striatum; Dogs; Efferent Pathways; Haloperidol; Humans; Levodopa; Movement; Nucleus Accumbens; Posture | 1985 |
Nervous mechanisms involved in experimentally induced extrapyramidal disturbances.
Topics: Animals; Basal Ganglia Diseases; Benztropine; Brain; Cats; Caudate Nucleus; Cerebellar Nuclei; Chlorpromazine; Corpus Striatum; Disease Models, Animal; Dopamine; Haloperidol; Haplorhini; Humans; Levodopa; Movement Disorders; Olivary Nucleus; Parkinson Disease; Putamen; Rats; Red Nucleus; Substantia Nigra; Thalamic Nuclei; Tremor | 1974 |
Catecholaminergic control of gonadotropin and prolactin secretion with particular reference to the possible participation of dopamine.
Topics: Animals; Brain Mapping; Castration; Dihydroxyphenylalanine; Dopamine; Drug Interactions; Electric Stimulation; Epinephrine; Estrogens; Female; Fenclonine; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Haloperidol; Hypothalamus; In Vitro Techniques; Levodopa; Luteinizing Hormone; Male; Norepinephrine; Pargyline; Phenoxybenzamine; Pimozide; Progesterone; Prolactin; Propranolol; Rats; Serine; Synaptic Transmission; Thiocarbamates; Thyrotropin-Releasing Hormone; Time Factors | 1974 |
Animal models of tardive dyskinesia: their use in the search for new treatment methods.
Topics: Age Factors; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Carbidopa; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Combinations; Drug Interactions; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Haplorhini; Humans; Levodopa; Lithium; Male; Parasympatholytics; Rats; Receptors, Dopamine; Stereotyped Behavior | 1983 |
Dopamine receptors in the basal ganglia: relevance to Parkinson's disease.
Topics: Basal Ganglia; Basal Ganglia Diseases; Brain; Clozapine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Humans; Levodopa; Male; Neostriatum; Neural Pathways; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1993 |
13 trial(s) available for haloperidol and levodopa
Article | Year |
---|---|
Studies on the anti-dyskinesia effect of apomorphine in man.
Topics: Administration, Oral; Adult; Aged; Apomorphine; Clinical Trials as Topic; Drug Evaluation; Female; Haloperidol; Humans; Huntington Disease; Injections, Intravenous; Levodopa; Male; Middle Aged; Movement Disorders | 1976 |
Meige disease: striatal dopaminergic preponderance.
Topics: Aged; Apomorphine; Basal Ganglia; Blepharospasm; Clinical Trials as Topic; Diagnosis, Differential; Eyelid Diseases; Facial Muscles; Female; Haloperidol; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Physostigmine; Placebos | 1979 |
The effects of levodopa and haloperidol on flash and pattern ERGs and VEPs in normal humans.
Topics: Adult; Double-Blind Method; Electroretinography; Evoked Potentials, Visual; Female; Haloperidol; Humans; Levodopa; Male; Pattern Recognition, Visual; Photic Stimulation; Random Allocation; Retina | 1990 |
Is there a common dopaminergic basis of time perception and reaction time?
Topics: Adult; Benserazide; Brain; Clinical Trials as Topic; Dopamine Agents; Double-Blind Method; Drug Combinations; Haloperidol; Humans; Hydrazines; Levodopa; Male; Reaction Time; Receptors, Dopamine; Time Perception | 1989 |
Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs.
Topics: Administration, Oral; Adult; Analysis of Variance; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Electromyography; Evoked Potentials, Motor; Female; Haloperidol; Humans; Levodopa; Magnetics; Male; Motor Cortex; Physical Stimulation; Reference Values; Selegiline; Sulpiride | 1997 |
Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans.
Topics: Adult; Algorithms; Behavior; Computer Simulation; Computers; Dopamine; Dopamine Agents; Dopamine Antagonists; Female; Forecasting; Haloperidol; Humans; Learning; Levodopa; Male; Models, Neurological; Neostriatum; Punishment; Reward | 2006 |
Dopamine modulates reward system activity during subconscious processing of sexual stimuli.
Topics: Adolescent; Adult; Brain; Brain Mapping; Dopamine; Dopamine Agents; Double-Blind Method; Haloperidol; Humans; Levodopa; Magnetic Resonance Imaging; Male; Motivation; Reward; Sexual Behavior; Unconscious, Psychology | 2012 |
Dopamine-dependent architecture of cortico-subcortical network connectivity.
Topics: Brain; Brain Mapping; Dopamine; Dopamine Agents; Haloperidol; Humans; Image Interpretation, Computer-Assisted; Impulsive Behavior; Levodopa; Magnetic Resonance Imaging; Male; Nerve Net; Rest; Reward; Young Adult | 2013 |
Dopaminergic modulation of probabilistic reasoning and overconfidence in errors: a double-blind study.
Topics: Adult; Cognition; Cross-Over Studies; Decision Making; Delusions; Dopamine Agonists; Dopamine Antagonists; Double-Blind Method; Female; Haloperidol; Humans; Judgment; Levodopa; Logic; Male; Schizophrenia; Schizophrenic Psychology; Young Adult | 2014 |
Effects of dopaminergic modulation on automatic semantic priming: a double-blind study.
Topics: Adult; Cross-Over Studies; Dopamine; Dopamine Agents; Dopamine Antagonists; Double-Blind Method; Female; Haloperidol; Humans; Levodopa; Male; Pattern Recognition, Visual; Reaction Time; Reading; Repetition Priming; Semantics; Speech; Young Adult | 2014 |
Dopamine effects on evidence gathering and integration.
Topics: Adolescent; Adult; Cross-Over Studies; Decision Making; Dopamine; Dopamine Agents; Double-Blind Method; Female; Haloperidol; Humans; Levodopa; Linear Models; Male; Neuropsychological Tests; Problem Solving; Young Adult | 2015 |
Antipsychotics decrease response confidence.
Topics: Adult; Antipsychotic Agents; Cross-Over Studies; Delusions; Dopamine Agents; Double-Blind Method; Female; Haloperidol; Humans; Levodopa; Male; Schizophrenia; Surveys and Questionnaires; Young Adult | 2016 |
A proof-of-principle study of the effect of combined haloperidol and levodopa administration on working memory-related brain activation in humans.
Topics: Adult; Affect; Brain; Cross-Over Studies; Drug Interactions; Haloperidol; Healthy Volunteers; Humans; Levodopa; Magnetic Resonance Imaging; Male; Memory, Short-Term; Neuroimaging; Young Adult | 2018 |
268 other study(ies) available for haloperidol and levodopa
Article | Year |
---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice.
Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Brain; Catalepsy; Glutathione; Glutathione Peroxidase; Haloperidol; Male; Malondialdehyde; Mice; Oxidative Stress; Parkinson Disease; Pyrimidines; Superoxide Dismutase; Thiourea; Urea | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model.
Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 7; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Stability; Enzyme Inhibitors; Humans; Imidazoles; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Molecular Structure; Parkinson Disease; Pyridones; Recombinant Proteins; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Somatic profiles in chronic schizophrenia.
Topics: Antipsychotic Agents; Chronic Disease; Folic Acid Deficiency; Haloperidol; Humans; Hypoglycemia; Hypothyroidism; Iodine Radioisotopes; Levodopa; Middle Aged; Phenothiazines; Schizophrenia | 1976 |
A pharmacologic model of Huntington's chorea.
Topics: Animals; Carbachol; Catheterization; Clozapine; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Huntington Disease; Hydrazines; Levodopa; Male; Phentolamine; Rats; Trifluoperazine; Tyramine | 1976 |
Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
Topics: 5-Hydroxytryptophan; 5,6-Dihydroxytryptamine; Adrenal Glands; Animals; Apomorphine; Bromocriptine; Carbidopa; Clonidine; Dopamine; Drug Interactions; Haloperidol; Hydroxydopamines; Injections, Intraventricular; Kinetics; Levodopa; Male; Piribedil; Pituitary Gland; Rats; Serotonin; Serotonin Antagonists; Splanchnic Nerves; Tyrosine 3-Monooxygenase | 1977 |
Paradoxical response to dopamine agonists in tardive dyskinesia.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Apomorphine; Benztropine; Clozapine; Deanol; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Levodopa; Physostigmine; Receptors, Dopamine; Reserpine; Stimulation, Chemical; Thioridazine | 1977 |
The effect of dopaminergic modifiers on morphine-induced analgesia and respiratory depression.
Topics: Analgesics, Opioid; Animals; Dopamine; Drug Interactions; Haloperidol; Levodopa; Male; Mice; Morphine; Pimozide; Reaction Time; Respiration | 1979 |
The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the L-DOPA and (+)-amphetamine-induced waking EEG in the rat.
Topics: Animals; Antipsychotic Agents; Dextroamphetamine; Electroencephalography; Haloperidol; Levodopa; Male; Norepinephrine; Pimozide; Rats; Receptors, Adrenergic; Receptors, Dopamine; Sleep; Spiperone; Wakefulness | 1979 |
Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Dopamine Antagonists; Ergolines; Guinea Pigs; Haloperidol; Humans; Levodopa; Male; Motor Activity; Myoclonus; Receptors, Dopamine; Stereotyped Behavior; Tetrahydronaphthalenes | 1979 |
Is a dopaminergic system involved in thyrotropin releasing hormone induced hyperthermia and in its potentiation by amphetamine?
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Apomorphine; Chlorpromazine; Dopamine; Dopamine Agents; Female; Fever; Haloperidol; Levodopa; Methyltyrosines; Mice; Neurotransmitter Agents; p-Chloroamphetamine; Pimozide; Thyrotropin-Releasing Hormone | 1979 |
Hyperprolactinaemia in the spontaneously hypertensive rat.
Topics: Animals; Haloperidol; Hypertension; Hypothalamus; Immobilization; Levodopa; Male; Prolactin; Rats; Stress, Physiological; Thyrotropin-Releasing Hormone | 1979 |
Effect of haloperidol and L-dopa on plasma prolactin in stalk-sectioned and intact monkeys.
Topics: Animals; Female; Haloperidol; Haplorhini; Hypothalamus; Kinetics; Levodopa; Macaca mulatta; Prolactin | 1978 |
Experimental torticollis in the marmoset produced by injection of 6-hydroxydopamine into the ascending nigrostriatal pathway.
Topics: Amphetamine; Animals; Apomorphine; Benserazide; Callitrichinae; Disease Models, Animal; Drug Therapy, Combination; Haloperidol; Haplorhini; Hydroxydopamines; Hypothalamus; Levodopa; Locus Coeruleus; Male; Torticollis | 1979 |
Histochemical and chronobiological studies on uptake of L-DOPA by granulocytes--its promotion and suppression.
Topics: Animals; Dopamine; Glycogen; Granulocytes; Haloperidol; Hormones; Levodopa; Male; Rats; Seasons; Steroids; Tranquilizing Agents | 1978 |
Effect of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenance.
Topics: Animals; Avoidance Learning; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain Chemistry; Dopamine; Electroshock; Female; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Norepinephrine; Parasympathetic Nervous System; Physostigmine; Scopolamine; Serotonin; Sympathetic Nervous System | 1979 |
Deficits of escape performance following catecholamine depletion: implications for behavioral deficits induced by uncontrollable stress.
Topics: Animals; Avoidance Learning; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain Chemistry; Catecholamines; Dopamine; Haloperidol; Humans; Levodopa; Male; Methyltyrosines; Mice; Reserpine; Stress, Psychological | 1979 |
Effects of d-amphetamine, maprotiline, L-dopa, and haloperidol on the components of the predatory behavior of the ferret, Putorius furo L.
Topics: Animals; Anthracenes; Appetitive Behavior; Behavior, Animal; Carnivora; Dextroamphetamine; Ferrets; Haloperidol; Levodopa; Male; Maprotiline; Predatory Behavior; Time Factors | 1979 |
Monoaminergic mechanisms of stimulation-produced analgesia.
Topics: 5-Hydroxytryptophan; Analgesia; Animals; Apomorphine; Brain; Cerebral Aqueduct; Disulfiram; Dopamine; Electric Stimulation; Fenclonine; Haloperidol; Levodopa; Male; Methyltyrosines; Norepinephrine; Pain; Pimozide; Rats; Reaction Time; Receptors, Drug; Serotonin; Tetrabenazine | 1975 |
Involvement of biogenic amines in drug-induced aggressive pecking in chicks.
Topics: Aggression; Animals; Animals, Newborn; Antidepressive Agents; Biogenic Amines; Chickens; Dextroamphetamine; Dopamine; Female; Fenclonine; Haloperidol; Humans; Imipramine; Iprindole; Levodopa; Male; Methysergide; Pargyline; Phentolamine; Propranolol; Serotonin | 1975 |
Effects of levodopa and dopamine of plasma glucose concentration in mice.
Topics: Animals; Apomorphine; Benserazide; Blood Glucose; Carbidopa; Cyproheptadine; Dopamine; Fatty Acids, Nonesterified; Fenclonine; Haloperidol; Insulin; Levodopa; Liver Glycogen; Male; Methysergide; Mice; Nialamide; Pargyline; Pimozide; Time Factors | 1977 |
Dopaminergic control of adenohypophyseal growth after oestrogens: negative results with L-DOPA, RO-4-4602, alpha-methyl-DOPA, apomorphine, haloperidol, pyridoxine and cyproheptadine.
Topics: Animals; Apomorphine; Benserazide; Cyproheptadine; Estrogens; Haloperidol; Levodopa; Pituitary Gland, Anterior; Pyridoxine; Rats; Thyroxine-Binding Proteins | 1978 |
[Participation of monoaminergic mechanisms and the striatum in the development of "petit mal" induced by corazole].
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Biogenic Amines; Chlorpromazine; Corpus Striatum; Drug Interactions; Electroencephalography; Epilepsy, Absence; Fenclonine; Haloperidol; Levodopa; Male; Pentylenetetrazole; Rats | 1978 |
Cyclic AMP in cerebrospinal fluid: accumulaiton following probenecid and biogenic amines.
Topics: Animals; Biogenic Amines; Catecholamines; Cyclic AMP; Dopamine; Haloperidol; Histamine; Injections, Intraperitoneal; Injections, Intravenous; Injections, Spinal; Isoproterenol; Levodopa; Male; Norepinephrine; Probenecid; Rabbits; Stimulation, Chemical | 1975 |
Dopaminergic mechanisms of opiate actions in brain.
Topics: Analgesics; Animals; Brain; Dopamine; Drug Synergism; Drug Tolerance; Haloperidol; Humans; Levodopa; Male; Mice; Morphine; Morphine Dependence; Motor Activity; Naloxone; Reaction Time; Synapses; Synaptic Transmission | 1975 |
Modification of involuntary movements by centrally acting drugs.
Topics: Aminooxyacetic Acid; Animals; Atropine; Bicuculline; Bromocriptine; Dopamine; Haloperidol; Haplorhini; Levodopa; Movement Disorders; Physostigmine; Picrotoxin; Piperazines; Piribedil; Receptors, Drug; Synaptic Transmission; Thalamic Nuclei; Theophylline | 1975 |
[Effect of catecholaminergic substances on the proconvulsive properties of the caudate nucleus].
Topics: Animals; Apomorphine; Behavior, Animal; Caudate Nucleus; Chlorpromazine; Disulfiram; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Electrodes, Implanted; Electroencephalography; Haloperidol; Levodopa; Male; Methyltyrosines; Neural Inhibition; Rats; Seizures; Sympathomimetics; Synaptic Transmission; Time Factors | 1975 |
[Letter: Narcolepsy. Suppression of paradoxical sleep by L-dopa].
Topics: Catecholamines; Cyproterone; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Narcolepsy; Serotonin; Sleep, REM; Vanilmandelic Acid | 1976 |
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria | 1975 |
The role of dopamine and serotonin in the prolongation of post-decapitation convulsions in mice.
Topics: 5-Hydroxytryptophan; Animals; Benserazide; Brain; Decerebrate State; Ditiocarb; Dopamine; Fenclonine; Haloperidol; Levodopa; Male; Mice; Norepinephrine; Seizures; Serotonin; Serotonin Antagonists; Time Factors | 1976 |
beta-Adrenoceptor stimulation of exocrine secretion from the rat pancreas.
Topics: Acetylcholine; Animals; Atropine; Catecholamines; Dopamine; Haloperidol; Isoproterenol; Levodopa; Male; Myocardial Contraction; Pancreas; Phenoxybenzamine; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Secretin; Spinal Cord; Sympathomimetics; Vagotomy | 1978 |
Facilitatory effect of naloxone and involvement of specific ligand-opiate receptor system in the antinociceptive effects of non-opioid drugs.
Topics: Analgesics; Animals; Baclofen; Benperidol; Haloperidol; Levodopa; Male; Mice; Naloxone; Phosphodiesterase Inhibitors; Pimozide; Receptors, Opioid; Sympathomimetics | 1978 |
On certain relationships between gamma-aminobutyric acid (GABA) and dopaminergic agents in pentylenetetrazol convulsions.
Topics: Amantadine; Animals; Apomorphine; Dextroamphetamine; Ditiocarb; Dopamine; Drug Interactions; gamma-Aminobutyric Acid; Haloperidol; Levodopa; Male; Mice; Pentylenetetrazole; Seizures | 1978 |
Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
Topics: Aminooxyacetic Acid; Animals; Apomorphine; Behavior; Corpus Striatum; Diazepam; Ditiocarb; Dopamine; gamma-Aminobutyric Acid; Haloperidol; Humans; Levodopa; Male; Methyltyrosines; Mice; Parasympathetic Nervous System; Picrotoxin; Semicarbazides; Stereotyped Behavior; Synaptic Transmission | 1978 |
Overnight sleep EEG and cerebrospinal fluid monoamines in seizures induced by movement.
Topics: Child; Electroencephalography; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Movement; Pedigree; Phenylacetates; Phenytoin; Seizures; Sleep; Sleep, REM | 1979 |
Dopamine-induced neurogenic vasodilatation in isolated perfused muscle preparation of the dog.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Animals; Apomorphine; Atropine; Autonomic Fibers, Preganglionic; Blood Vessels; Diphenhydramine; Dogs; Dopamine; Dopamine Antagonists; Female; Ganglia, Autonomic; Haloperidol; Hindlimb; Histamine; In Vitro Techniques; Levodopa; Male; Muscles; Perfusion; Phentolamine; Reflex; Sympathetic Nervous System; Vascular Resistance | 1975 |
Amines and the rat exocrine pancreas: (3) Effects of amines on pancreatic secretion.
Topics: 5-Hydroxytryptophan; Amines; Animals; Bicarbonates; Haloperidol; Levodopa; Male; Monoamine Oxidase Inhibitors; Pancreatic Juice; Phenoxybenzamine; Phenylephrine; Proteins; Rats; Secretin; Secretory Rate; Sulpiride | 1979 |
The treatment of the choreas and athetotic dystonias.
Topics: Adult; Athetosis; Benzodiazepines; Child; Chorea; Dystonia; Haloperidol; Humans; Levodopa; Movement Disorders; Phenelzine; Phenothiazines; Pimozide; Tetrabenazine; Valproic Acid | 1979 |
Acute dystonia as an idiosyncratic response to neuroleptics in baboons.
Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Haloperidol; Haplorhini; Humans; Levodopa; Movement Disorders; Papio; Parasympatholytics; Physostigmine; Pimozide; Receptors, Dopamine; Reserpine; Syndrome; Tranquilizing Agents | 1977 |
Behavioral study on the interactions between trazodone and L-dopa.
Topics: Animals; Behavior, Animal; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Muscle Rigidity; Piperazines; Time Factors; Trazodone | 1979 |
[Role of the catecholaminergic mechanisms and of the caudate nucleus in the development of generalized convulsions caused by the parenteral administration of penicillin].
Topics: Animals; Apomorphine; Cats; Caudate Nucleus; Chlorpromazine; Electric Stimulation; Electroencephalography; Female; Haloperidol; Levodopa; Male; Penicillin G; Receptors, Adrenergic; Seizures; Time Factors | 1979 |
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Corpus Striatum; Dyskinesia, Drug-Induced; Haloperidol; Levodopa; Male; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Drug; Spiperone | 1979 |
Central dopamine receptors regulate blood eosinophilia in the rat.
Topics: Animals; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Benzyl Alcohols; Brain; Dihydroxyphenylalanine; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Eosinophils; Haloperidol; Hydrazines; Hypophysectomy; Leukocyte Count; Levodopa; Male; Phenylthiourea; Rats; Receptors, Dopamine | 1979 |
Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: growth hormone and prolactin response to stimuli.
Topics: Adult; Female; Growth Hormone; Haloperidol; Humans; Hypothalamus; Levodopa; Male; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia | 1979 |
Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
Topics: Animals; Apomorphine; Benserazide; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Clonidine; Dopamine; Drug Interactions; Female; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Norepinephrine; Pentylenetetrazole; Phenoxybenzamine; Propranolol; Receptors, Dopamine; Reserpine; Seizures; Tetrabenazine | 1979 |
[On a muscular dystony case from manganism. Therapeutic clinic considerations (author's transl)].
Topics: Benserazide; Diazepam; Dystonia; Haloperidol; Humans; Hydrazines; Levodopa; Male; Manganese; Middle Aged | 1979 |
[Central effects of beta-phenylethylamines. (8). Increase in spontaneous motor activities of mice caused by intracerebrally administered metaramino].
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Isocarboxazid; Levodopa; Male; Metaraminol; Methyltyrosines; Mice; Motor Activity; Time Factors | 1977 |
Influence of dopaminergic agonists upon body temperature and behavior of spontaneously hypertensive and normotensive rats.
Topics: Animals; Apomorphine; Behavior, Animal; Body Temperature; Carbidopa; Dopamine; Haloperidol; Humans; Hypertension; Levodopa; Male; Motor Activity; Rats; Stereotyped Behavior | 1978 |
[Relationship between gnawing compulsion and central dopaminergic mechanism in guinea pigs (author's transl)].
Topics: Amphetamine; Animals; Apomorphine; Behavior; Benserazide; Dopamine; Guinea Pigs; Haloperidol; Humans; Levodopa; Male; Methyltyrosines; Pimozide; Stereotyped Behavior | 1979 |
[Drug modification of the dopaminergic system in chorea].
Topics: Adult; Aged; Chorea; Extrapyramidal Tracts; Female; Haloperidol; Humans; Levodopa; Male; Middle Aged; Receptors, Dopamine | 1978 |
A method for mechanographical recording of muscle tone in the rat: the effect of some antiparkinsonian drugs on rigidity induced by reserpine.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Carbidopa; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Male; Muscle Rigidity; Muscle Tonus; Myography; Rats; Reserpine | 1978 |
Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals.
Topics: Acetylcholine; Animals; Bungarotoxins; Corpus Striatum; Dopamine; Haloperidol; In Vitro Techniques; Levodopa; Potassium; Receptors, Dopamine; Receptors, Nicotinic; Sheep; Synaptosomes; Tyrosine | 1978 |
Receptor basis for dopaminergic supersensitivity in Parkinson's disease.
Topics: Adult; Aged; Apomorphine; Caudate Nucleus; Dopamine; Haloperidol; Homovanillic Acid; Humans; Levodopa; Middle Aged; Parkinson Disease; Putamen; Receptors, Dopamine; Synaptic Membranes | 1978 |
Investigation of a dopaminergic mechanism for regulating oxytocin release.
Topics: Animals; Carbachol; Depression, Chemical; Dopamine; Female; Haloperidol; Hypothalamo-Hypophyseal System; In Vitro Techniques; Levodopa; Male; Neurophysins; Oxytocin; Phenylephrine; Pituitary Gland, Posterior; Pregnancy; Rats | 1978 |
On certain effects of dopaminergic agents in pentylenetetrazol convulsions.
Topics: Amantadine; Animals; Benserazide; Dextroamphetamine; Dopamine; Drug Interactions; Haloperidol; Levodopa; Male; Mice; Pentylenetetrazole; Rats; Seizures | 1978 |
Central effects of thyrotropin-releasing factor (TRF); interaction with some antipsychotic drugs.
Topics: Animals; Behavior, Animal; Chlorpromazine; Drug Interactions; Haloperidol; Injections, Intraventricular; Levodopa; Mice; Reserpine; Sulpiride; Thyrotropin-Releasing Hormone; Time Factors | 1976 |
Effect of centrally acting drugs on experimental torticollis in monkeys.
Topics: Acetates; Alkaloids; Aminooxyacetic Acid; Animals; Brain Stem; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; Electromyography; Haloperidol; Haplorhini; Harmaline; Humans; Levodopa; Macaca mulatta; Methyltyrosines; Muscle Tonus; Pimozide; Tegmentum Mesencephali; Torticollis | 1976 |
Drug-induced rotation in rats without lesions: behavioral and neurochemical indices of a normal asymmetry in nigro-striatal function.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Corpus Striatum; Dextroamphetamine; Dominance, Cerebral; Dopamine; Female; Haloperidol; Humans; Levodopa; Norepinephrine; Rats; Scopolamine; Stereotyped Behavior; Substantia Nigra | 1976 |
Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.
Topics: Adenylyl Cyclases; Animals; Corpus Striatum; Depression, Chemical; Dopamine; Haloperidol; In Vitro Techniques; Levodopa; Rats; Receptors, Dopamine; Trifluoperazine | 1977 |
Interelationships between dopaminergic and cholinergic systems in the cerebral cortex.
Topics: Acetylcholine; Animals; Apomorphine; Benserazide; Bromocriptine; Cats; Cerebral Cortex; Dopamine; Female; Haloperidol; Levodopa; Male; Parasympathetic Nervous System; Rats; Time Factors | 1977 |
Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons.
Topics: Action Potentials; Animals; Apomorphine; Caudate Nucleus; Corpus Striatum; Haloperidol; Injections; Injections, Intravenous; Levodopa; Male; Morphine; Narcotic Antagonists; Neurons; Rats; Substantia Nigra; Time Factors | 1977 |
In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists.
Topics: Animals; Apomorphine; Cerebellum; Cerebral Cortex; Corpus Striatum; Dextroamphetamine; Haloperidol; Homovanillic Acid; Levodopa; Male; Mice; Pimozide; Receptors, Dopamine; Sulpiride | 1977 |
Effect of chronic neuroleptic or L-DOPA administration on GABA levels in the rat substantia nigra.
Topics: Aminobutyrates; Animals; Clozapine; Dibenzazepines; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Haloperidol; Levodopa; Male; Rats; Substantia Nigra | 1977 |
General discussion of drug therapy in dystonia.
Topics: Adolescent; Age Factors; Baclofen; Cannabis; Carbamazepine; Child; Child, Preschool; Dystonia Musculorum Deformans; Female; Haloperidol; Humans; Levodopa; Male; Phytotherapy; Torticollis | 1976 |
Suppression of ethanol withdrawal by dopamine.
Topics: Animals; Dopamine; Ethanol; Haloperidol; Humans; Levodopa; Mice; Seizures; Substance Withdrawal Syndrome; Time Factors | 1976 |
[Effect of striatectomy on the course of corazole seizures in rats].
Topics: Animals; Apomorphine; Chlorpromazine; Corpus Striatum; Electroencephalography; Female; Haloperidol; Levodopa; Male; Myoclonus; Pentylenetetrazole; Rats; Seizures | 1976 |
[Facilitation of the effects of L-DOPA by alpha-methyldopa].
Topics: Animals; Blood Pressure; Catalepsy; Cats; Dopamine; Drug Interactions; Drug Therapy, Combination; Haloperidol; Humans; Levodopa; Male; Methyldopa; Mice; Nictitating Membrane; Reserpine | 1976 |
alpha and beta Dopamine receptors?
Topics: Apomorphine; Chorea; Haloperidol; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Torticollis | 1976 |
On the brain monoaminergic systems relating to ejaculation. I. Brain dopamine and ejaculation.
Topics: Animals; Brain; Brain Chemistry; Dogs; Dopamine; Ejaculation; Haloperidol; Levodopa; Male; Norepinephrine; Rats; Reserpine; Serotonin; Tetrabenazine | 1976 |
Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.
Topics: Animals; Apomorphine; Benserazide; Clonidine; Dextroamphetamine; Dopamine; Female; Haloperidol; Hypophysectomy; Levodopa; Male; Methyltyrosines; Piribedil; Pituitary Gland; Prolactin; Rats; Reserpine; Sulpiride; Transplantation, Homologous | 1976 |
Effect of neuroleptic drugs on mouse jumping induced by L-DOPA in amphetamine treated mice.
Topics: Amphetamine; Animals; Behavior; Chlorpromazine; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Levodopa; Male; Mice; Pimozide; Promethazine; Psychotropic Drugs; Stereotyped Behavior; Thioridazine; Tranquilizing Agents | 1976 |
A study of endogenous dopamine metabolism in Gilles de la Tourette's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Dopamine; Epinephrine; Haloperidol; Homovanillic Acid; Humans; Imipramine; Levodopa; Male; Tourette Syndrome | 1976 |
A comparison of circling models for the detection of antiparkinson activity.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Behavior; Brain; Dextroamphetamine; Dopamine; Haloperidol; Humans; Isoquinolines; Levodopa; Male; Methylphenidate; Methyltyrosines; Piperazines; Rats; Reserpine; Rotation; Stereotaxic Techniques; Stereotyped Behavior; Substantia Nigra; Thalamic Nuclei | 1975 |
Role of the strio-pallidal system and motor cortex in induced circus movements in rats and cats.
Topics: Animals; Apomorphine; Brain Mapping; Cats; Chlorpromazine; Corpus Striatum; Dextroamphetamine; Drug Interactions; Female; Haloperidol; Levodopa; Locomotion; Male; Mesencephalon; Motor Cortex; Movement Disorders; Neural Pathways; Rats | 1975 |
Narcotic withdrawal like mouse jumping produced by amphetamine and L-DOPA.
Topics: Amphetamine; Animals; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Fluorometry; Haloperidol; Humans; Levodopa; Male; Mice; Motor Activity; Norepinephrine; Phentolamine; Pimozide; Substance Withdrawal Syndrome | 1975 |
The effect of dopaminergic stimulation and blockade on the nociceptive and antinociceptive responses of mice.
Topics: Analgesics; Animals; Apomorphine; Depression, Chemical; Dopamine; Haloperidol; Levodopa; Male; Mice; Morphine; Naloxone; Pain; Pimozide; Reaction Time; Receptors, Drug; Stimulation, Chemical | 1975 |
[Treatment of Parkinson's disease associated with psychosis].
Topics: Aged; Female; Haloperidol; Humans; Levodopa; Parkinson Disease; Psychotic Disorders | 1975 |
[Role of brain biogenic amines in the central thermoregulatory mechanism of the rat (author's transl)].
Topics: Adaptation, Physiological; Animals; Biogenic Amines; Blood Glucose; Body Temperature Regulation; Cerebral Ventricles; Dopamine; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Haloperidol; Hydroxydopamines; Hypothermia; Imipramine; Isoproterenol; Levodopa; Male; Norepinephrine; Oxygen Consumption; Phenoxybenzamine; Phenylephrine; Propranolol; Rats; Rectum; Serotonin; Skin Temperature | 1975 |
Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum.
Topics: Animals; Apomorphine; Basal Ganglia Diseases; Behavior; Biogenic Amines; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Chlorpromazine; Clozapine; Corpus Striatum; Dextroamphetamine; Diazepam; Dopamine; Haloperidol; Humans; Hydroxydopamines; Levodopa; Male; Metoclopramide; Mice; Motor Activity; Pentobarbital; Phenoxybenzamine; Pimozide; Promethazine; Stereotyped Behavior; Tranquilizing Agents | 1975 |
[Behavior pharmacology of maprotiline, a new antidepressant].
Topics: Aggression; Amitriptyline; Animals; Anthracenes; Apomorphine; Behavior, Animal; Body Temperature; Catalepsy; Escape Reaction; Eyelids; Haloperidol; Humans; Imipramine; Levodopa; Maprotiline; Methamphetamine; Mice; Motor Activity; Oxotremorine; Physostigmine; Rats; Reserpine; Sleep; Tetrabenazine | 1975 |
Neuroleptics and the corpus striatum: clinical implications.
Topics: Acetylcholine; Basal Ganglia Diseases; Benztropine; Corpus Striatum; Dopamine; Fluphenazine; Haloperidol; Humans; Levodopa; Models, Neurological; Movement Disorders; Parkinson Disease; Reserpine; Schizophrenia; Tranquilizing Agents; Trihexyphenidyl | 1976 |
[The effect of stimulation and blockade of the dopaminergic system on the choice of behavioral strategy by rats in the shuttle box].
Topics: Animals; Benserazide; Brain; Choice Behavior; Drug Combinations; Haloperidol; Levodopa; Male; Physical Stimulation; Rats; Reaction Time; Receptors, Dopamine; Stress, Psychological | 1992 |
Effects of pharmacological manipulation of dopaminergic and cholinergic neurotransmission in genetically dystonic hamsters.
Topics: Acetylcholine; Animals; Apomorphine; Behavior, Animal; Carbidopa; Cricetinae; Dopamine; Drug Interactions; Dystonia; Haloperidol; Levodopa; Mesocricetus; Motor Activity; Mutation; Pilocarpine; Synaptic Transmission; Trihexyphenidyl | 1992 |
L-dopa is protective against indomethacin-induced small intestinal ulceration in the rat: possible role of an alpha-2-adrenergic mechanism.
Topics: Animals; Clonidine; Haloperidol; Indomethacin; Intestinal Diseases; Intestinal Mucosa; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Ulcer; Yohimbine | 1992 |
Modulation by dopamine of [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP, a phencyclidine derivative) binding to the dopamine uptake complex.
Topics: alpha-Methyltyrosine; Animals; Benserazide; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Haloperidol; In Vitro Techniques; Levodopa; Male; Membrane Proteins; Methyltyrosines; Mice; Nerve Tissue Proteins; Phencyclidine; Piperazines; Rats; Reserpine | 1991 |
A new motor test sensitive to aging and dopaminergic function.
Topics: Aging; Animals; Body Weight; Dextroamphetamine; Dopamine; Haloperidol; Levodopa; Male; Motor Activity; Neuropsychological Tests; Rats; Rats, Inbred Strains | 1991 |
Dopaminergic activity and idiopathic edema.
Topics: Adult; Brain; Diuresis; Dopamine; Dyskinesia, Drug-Induced; Edema; Female; Galactorrhea; Haloperidol; Humans; Levodopa; Receptors, Dopamine; Substance Withdrawal Syndrome | 1991 |
Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Analysis of Variance; Animals; Animals, Newborn; Apomorphine; Autoradiography; Corpus Striatum; Haloperidol; Hydroxydopamines; Levodopa; Mazindol; Motor Activity; Neurotoxins; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Stereotyped Behavior; Tritium | 1991 |
[Pharmacological effects of the novel dopamine uptake inhibitor 1-[2-[bis(4-fluorophenyl)-methoxy]ethyl]-4-(3-phenylpropyl) piperazine dihydrochloride (I-893) on the central nervous system].
Topics: Animals; Barbiturates; Body Temperature; Catalepsy; Dogs; Dopamine; Dose-Response Relationship, Drug; Electroencephalography; Haloperidol; Levodopa; Male; Methamphetamine; Mice; Motor Activity; Neurotransmitter Uptake Inhibitors; Piperazines; Rabbits; Rats; Rats, Inbred Strains; Sleep; Tremor; Tremorine | 1991 |
Mechanism of hyperalgesia in SART stressed (repeated cold stress) mice: antinociceptive effect of neurotropin.
Topics: 5-Hydroxytryptophan; Animals; Cold Temperature; Drug Interactions; Fenclonine; Haloperidol; Hyperalgesia; Levodopa; Male; Mice; Mice, Inbred Strains; Muscimol; Nociceptors; Phenoxybenzamine; Polysaccharides; Reserpine; Stress, Physiological | 1991 |
5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Animals; Anti-Arrhythmia Agents; Brain; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Homovanillic Acid; Levodopa; Male; Nomifensine; Piperidines; Rats; Rats, Inbred Strains; Ritanserin; Serotonin Antagonists; Stereoisomerism; Time Factors | 1991 |
Further studies on the neuroleptic profile of manassantin A.
Topics: Adenylyl Cyclase Inhibitors; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Binding, Competitive; Blepharoptosis; Body Temperature; Catalepsy; Furans; Haloperidol; In Vitro Techniques; Levodopa; Lignans; Male; Mice; Norepinephrine; Pentobarbital; Physostigmine; Plants, Medicinal; Stereotyped Behavior | 1990 |
Dopaminergic drugs influence the intensity of catalepsy induced by microinjections of carbachol into the reticular formation.
Topics: Animals; Apomorphine; Brain Stem; Carbachol; Catalepsy; Dopamine Agents; Haloperidol; Injections; Injections, Subcutaneous; Levodopa; Male; Microinjections; Motor Activity; Rats; Rats, Inbred Strains; Reticular Formation; Stereotyped Behavior | 1990 |
Monoamine oxidase and oxidative stress at dopaminergic synapses.
Topics: Animals; Clorgyline; Corpus Striatum; Dopamine; Glutathione; Glutathione Reductase; Haloperidol; In Vitro Techniques; Levodopa; Male; Mice; Monoamine Oxidase; Oxidation-Reduction; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stress, Physiological; Substantia Nigra; Synapses; Synaptosomes | 1990 |
[Problems of diagnosis and treatment of deforming muscular dystrophy in children].
Topics: Child; Diagnosis, Differential; Drug Therapy, Combination; Haloperidol; Hand Deformities, Acquired; Humans; Hyperkinesis; Levodopa; Muscle Hypertonia; Muscular Dystrophies; Spastic Paraplegia, Hereditary | 1990 |
Facial dystonia: clinical features, prognosis and pharmacology in 31 patients.
Topics: Adult; Aged; Basal Ganglia Diseases; Botulinum Toxins; Drug Combinations; Female; Haloperidol; Humans; Levodopa; Male; Meige Syndrome; Middle Aged; Phenethylamines; Prognosis; Selegiline | 1989 |
Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain; Dopamine; Haloperidol; Levodopa; Male; Rats; Rats, Inbred Strains; Sulpiride | 1989 |
[Response to haloperidol and analysis of growth curve in hereditary progressive dystonia with marked diurnal fluctuation].
Topics: Body Height; Child; Circadian Rhythm; Dystonia; Female; Haloperidol; Humans; Levodopa | 1989 |
Role of renal catecholamines in the control of sodium and water excretion: lack of natriuresis by endogenous dopamine in the rat kidney.
Topics: Animals; Body Water; Cyclic AMP; Epinephrine; Haloperidol; Hydroxydopamines; Kidney; Levodopa; Natriuresis; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sodium; Sodium-Potassium-Exchanging ATPase | 1987 |
[Distribution of neurotensin-like immunoreactivity (NTLI) and neurotensin receptor in the rat brain and effects of various drugs on NTLI concentration and NT receptor in the rat cerebral cortex].
Topics: Animals; Brain; Cerebral Cortex; Dopamine; Haloperidol; In Vitro Techniques; Injections, Intraventricular; Levodopa; Male; Methyldopa; Neuropeptides; Rats; Receptors, Neurotensin; Receptors, Neurotransmitter | 1988 |
Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain.
Topics: Adrenergic alpha-Agonists; Animals; Antipsychotic Agents; Azepines; Behavior, Animal; Benzamides; Brain; Haloperidol; Levodopa; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride; Salicylamides | 1988 |
Potentiation of central effects of L-dopa by an inhibitor of catechol-O-methyltransferase.
Topics: Animals; Behavior, Animal; Catalepsy; Catechol O-Methyltransferase Inhibitors; Central Nervous System; Haloperidol; Levodopa; Male; Motor Activity; Phenethylamines; Propiophenones; Rats; Selegiline; Specific Pathogen-Free Organisms | 1987 |
Blockade of D-1 dopamine receptors by SCH 23390 prevents EEG and behavioral activation induced by L-dopa.
Topics: Animals; Behavior, Animal; Benzazepines; Electroencephalography; Haloperidol; Levodopa; Male; Rabbits; Receptors, Dopamine; Receptors, Dopamine D1; Sulpiride | 1987 |
Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Basal Ganglia; Benzazepines; Corpus Striatum; Denervation; Dextroamphetamine; Ergolines; Female; Flunarizine; Functional Laterality; Haloperidol; Levodopa; Neural Pathways; Parkinson Disease; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Substantia Nigra | 1988 |
Increase of rat serum prolactin by adenosine analogs and their blockade by the methylxanthine aminophylline.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); alpha-Methyltyrosine; Aminophylline; Animals; Bromocriptine; Corpus Striatum; Haloperidol; In Vitro Techniques; Levodopa; Male; Methyltyrosines; Phenylisopropyladenosine; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic | 1985 |
Influence of some dopaminoceptor agents on nitrazepam-induced sleep in the domestic fowl (Gallus domesticus) and rats.
Topics: Aminooxyacetic Acid; Animals; Apomorphine; Chickens; Dopamine; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Haloperidol; Levodopa; Male; Nitrazepam; Norepinephrine; Phentolamine; Pimozide; Rats; Receptors, Dopamine; Receptors, GABA-A; Sleep; Tetrahydronaphthalenes | 1986 |
Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans.
Topics: Adult; Aged; Brain; Carbidopa; Dopamine; Evoked Potentials, Visual; Female; Haloperidol; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Synaptic Transmission; Visual Pathways | 1986 |
Changes in the 5-HT-binding sites in the cerebral cortex, striatum and hypothalamus of rats during ageing and under the effect of dopaminergic agents.
Topics: Aging; Animals; Binding Sites; Cerebral Cortex; Corpus Striatum; Haloperidol; Hypothalamus; Levodopa; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin | 1987 |
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Clorgyline; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Nomifensine; Oxotremorine; Pargyline; Piperidines; Pyridazines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stereotyped Behavior | 1987 |
Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys.
Topics: Acetylcholine; Amphetamine; Animals; Behavior, Animal; Cognition Disorders; Dopamine; Haloperidol; Lead Poisoning; Levodopa; Macaca mulatta; Physostigmine; Scopolamine; Sulpiride | 1987 |
Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: behavioural correlates in rodent and primate.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain; Callitrichinae; Catalepsy; Dopamine; Dopamine Antagonists; Haloperidol; Injections; Ketotifen; Levodopa; Male; Motor Activity; Nucleus Accumbens; Pyridines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior | 1987 |
Effects of various drugs on thyrotropin secretion in rats.
Topics: 5-Hydroxytryptophan; Animals; Dose-Response Relationship, Drug; Endorphins; Fenclonine; Haloperidol; Hypothalamus; Levodopa; Male; Melatonin; Phenytoin; Protein Precursors; Rats; Rats, Inbred Strains; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors | 1985 |
Attenuation of pentylenetetrazol kindling of epileptogenesis in rats by dopaminergic agents.
Topics: Amantadine; Amphetamine; Animals; Epilepsy; Haloperidol; Kindling, Neurologic; Levodopa; Male; Metoclopramide; Pentylenetetrazole; Rats | 1988 |
Chronic l-dopa fails to lessen rebound enhancement of self-stimulation after chronic haloperidol.
Topics: Animals; Drug Interactions; Electric Stimulation; Haloperidol; Hypothalamus; Levodopa; Male; Rats; Rats, Inbred Strains; Self Stimulation | 1988 |
Studies of the thyrotropic function of the adenopituitary of the offspring of rats treated during pregnancy with dopaminergic agents.
Topics: Animals; Bromocriptine; Female; Haloperidol; Levodopa; Male; Pituitary Gland, Anterior; Pregnancy; Rats; Rats, Inbred Strains; Thyrotropin | 1988 |
[The effect of haloperidol and L-dopa on age-dependent epileptic encephalopathy (ADEE)].
Topics: Adolescent; Age Factors; Electromyography; Epilepsy; Female; Haloperidol; Humans; Levodopa; Male; Sleep | 1988 |
[Difference in mechanism of action of sulpiride and haloperidol on dopamine brain turnover].
Topics: Animals; Brain; Dopamine; Haloperidol; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride | 1988 |
The influence of dopamine agonists and antagonists on gastric lesions in mice.
Topics: Animals; Bromocriptine; Dopamine Antagonists; Female; Haloperidol; Levodopa; Male; Mice; Mice, Inbred C3H; Pylorus; Stomach Ulcer | 1987 |
Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis.
Topics: Adult; Carbidopa; Drug Combinations; Haloperidol; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders | 1987 |
Biochemical and behavioural indices of striatal dopaminergic activity after 6-methyltetrahydropterin.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Catalepsy; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Levodopa; Male; Neurons; Pterins; Rats; Rats, Inbred Strains; Reserpine | 1987 |
Partial protection against hyperbaric oxygen induced convulsions by dopaminergic agents in mice: possible involvement of autoreceptors?
Topics: Animals; Antiparkinson Agents; Apomorphine; Body Temperature; Dose-Response Relationship, Drug; Haloperidol; Hyperbaric Oxygenation; Levodopa; Male; Mice; Mice, Inbred CBA; Piperidines; Reaction Time; Receptors, Dopamine; Respiration; Seizures | 1987 |
Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat.
Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Female; Haloperidol; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Muscle Rigidity; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Reserpine; Swimming; Sympatholytics; Time Factors; Tremor | 1987 |
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats.
Topics: Amantadine; Animals; Biperiden; Brain Chemistry; Bromocriptine; Carbidopa; Diazepam; Haloperidol; Levodopa; Methysergide; Naloxone; Rats | 1986 |
Reduction in paradoxical sleep after L-dopa administration in rats.
Topics: Animals; Benserazide; Electroencephalography; Haloperidol; Injections, Intraperitoneal; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sleep Stages; Sleep, REM | 1986 |
Dopamine antagonists induce gastric lesions in rats.
Topics: Animals; Bromocriptine; Domperidone; Dopamine Antagonists; Female; Haloperidol; Levodopa; Male; Metoclopramide; Rats; Rats, Inbred Strains; Stomach Ulcer | 1986 |
Differential changes in dopaminergic receptor sensitivity induced by agonist drugs.
Topics: Animals; Apomorphine; Benserazide; Brain Chemistry; Catalepsy; Drug Therapy, Combination; Haloperidol; Homovanillic Acid; Levodopa; Male; Mice; Mice, Inbred Strains; Receptors, Dopamine | 1985 |
Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Haloperidol; Levodopa; Male; Mice; Mice, Inbred C57BL; Nomifensine; Pyridines | 1985 |
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Drug Synergism; Fluoxetine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Nomifensine; Receptors, Dopamine; Reserpine | 1985 |
[Effect of dopaminergic pharmacological agents on thyrotropic hormone secretion by the hypophysis when stimulated with thyrotropin-releasing hormone].
Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Dopamine Antagonists; Haloperidol; Levodopa; Male; Pituitary Gland; Rats; Thyrotropin; Thyrotropin-Releasing Hormone | 1985 |
Simple method for evaluation of stimulatory effect of drugs on presynaptic dopamine receptors in mice.
Topics: Animals; Apomorphine; Haloperidol; Hydrazines; Hydroxydopamines; Levodopa; Male; Mice; Mice, Inbred Strains; Oxidopamine; Receptors, Dopamine | 1985 |
Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Benzazepines; Dihydroxyphenylalanine; Drug Interactions; Ergolines; Female; Flupenthixol; Haloperidol; Hydroxydopamines; Levodopa; Male; Motor Activity; Oxidopamine; Pregnancy; Quinpirole; Rats; Receptors, Dopamine; Self Mutilation; Stereotyped Behavior | 1985 |
Central cholinergic-dopaminergic interaction in carbaryl-induced tremor.
Topics: Animals; Atropine; Carbaryl; Carbidopa; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Levodopa; Male; Rats; Receptors, Cholinergic; Receptors, Dopamine; Tremor | 1985 |
The role of dopamine in the formation of gastric ulcers in rats.
Topics: Animals; Apomorphine; Bromocriptine; Domperidone; Dopamine; Female; Haloperidol; Levodopa; Male; Rats; Rats, Inbred Strains; Stomach Ulcer; Sulpiride | 1985 |
The effect of central and peripheral dopamine-agonists on ventilation in the mouse.
Topics: Animals; Blood-Brain Barrier; Brain; Carbidopa; Chemoreceptor Cells; Dopamine; Drug Interactions; Haloperidol; Hypercapnia; Hypoxia; Kinetics; Levodopa; Male; Mice; Peripheral Nerves; Respiration | 1985 |
The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Corpus Striatum; Dextroamphetamine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Receptors, Dopamine; Reserpine; Spiperone | 1985 |
Influence of noncholinergic drugs on rat striatal acetylcholine levels.
Topics: Acetylcholine; Acetylcholinesterase; Acetyltransferases; Amantadine; Animals; Anti-Anxiety Agents; Apomorphine; Benzodiazepines; Biological Assay; Brain Chemistry; Choline; Corpus Striatum; Depression, Chemical; Haloperidol; Levodopa; Male; Methamphetamine; Rats; Rats, Inbred Strains; Reserpine; Stimulation, Chemical; Tyrosine 3-Monooxygenase | 1974 |
Dopaminergic and cholinergic mechanisms in relation to postural tremor in the monkey and circling movements in the cat.
Topics: Acetylcholine; Amphetamine; Animals; Cats; Corpus Striatum; Disease Models, Animal; Dopamine; Frontal Lobe; Haloperidol; Haplorhini; Levodopa; Mesencephalon; Methyltyrosines; Mice; Movement Disorders; Parkinson Disease; Posture; Rats; Reserpine; Substantia Nigra; Tegmentum Mesencephali; Thalamic Nuclei; Tremor | 1974 |
L-dopa hypotension in dogs: evidence for mediation through 5-HT release.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Pressure; Brain Chemistry; Carbidopa; Chlorpromazine; Depression, Chemical; Dogs; Drug Interactions; Female; Fenclonine; Haloperidol; Heart Rate; Levodopa; Male; Methysergide; Monoamine Oxidase Inhibitors; Norepinephrine; Reserpine; Serotonin; Time Factors; Yohimbine | 1974 |
Drug treatment of diseases characterized by abnormal movements.
Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; Myoclonus; Phenothiazines; Propranolol; Reserpine; Tetrabenazine; Tic Disorders; Torticollis; Tourette Syndrome; Tremor | 1973 |
Mechanisms involved in the control of extrapyramidal dysfunctions and in striatal dopamine synthesis.
Topics: Animals; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Bucladesine; Carbidopa; Carbon Radioisotopes; Corpus Striatum; Depression, Chemical; Dopamine; Drug Therapy, Combination; Haloperidol; Haplorhini; Levodopa; Receptors, Drug; Stimulation, Chemical; Tremor | 1974 |
Clinical features, etiology and treatment of facial dyskinesias in the elderly.
Topics: Age Factors; Aged; Brain; Brain Damage, Chronic; Brain Stem; Chorea; Dementia; Dopamine; Face; Female; Haloperidol; Humans; Intracranial Arteriosclerosis; Levodopa; Lip; Male; Movement Disorders; Parasympathomimetics; Parkinson Disease; Phenothiazines; Tongue | 1974 |
Clinical studies of dopaminergic mechanisms.
Topics: Antiparkinson Agents; Dioxoles; Dopamine; Drug Evaluation; Haloperidol; Homovanillic Acid; Humans; Levodopa; Parkinson Disease; Piperidines; Probenecid; Pyrimidines | 1974 |
Dopamine receptor in the reward system of the rat.
Topics: Amantadine; Animals; Apomorphine; Benzyl Compounds; Cortical Synchronization; Desipramine; Dihydroxyphenylalanine; Dopamine; Electrodes, Implanted; Electroencephalography; Haloperidol; Hydrazines; Hypothalamus; Levodopa; Male; Rats; Receptors, Drug; Reward; Self Stimulation; Time Factors | 1974 |
Enkephalin receptor changes in rat brain during aging.
Topics: Aging; Animals; Cerebral Cortex; Corpus Striatum; Haloperidol; Hypothalamus; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Opioid | 1984 |
[Relation between analgesic action and cyclic-AMP content in the rat brain after administration of several kinds of drugs].
Topics: Analgesics; Animals; Brain; Chlorpromazine; Cyclic AMP; Cyclic GMP; Female; Haloperidol; Levodopa; Lithium; Norepinephrine; Propranolol; Rats; Rats, Inbred Strains | 1984 |
Release of somatostatin and thyrotropin-releasing hormone from rat hypothalamic fragments in vitro.
Topics: Animals; Bromocriptine; Bucladesine; Calcium; Dopamine; Haloperidol; Hypothalamus; In Vitro Techniques; Levodopa; Male; Neurotransmitter Agents; Potassium; Rats; Somatostatin; Thyrotropin-Releasing Hormone; Veratridine | 1980 |
[Psychopharmacologic spectrum of melanostatin].
Topics: Aggression; Amantadine; Animals; Behavior, Animal; Biogenic Amines; Brain Chemistry; Catalepsy; Cats; Depression; Emotions; Fever; Haloperidol; Humans; Levodopa; Motor Activity; MSH Release-Inhibiting Hormone; Reserpine | 1980 |
The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists.
Topics: 4-Butyrolactone; Animals; Corpus Striatum; Dopamine; Haloperidol; In Vitro Techniques; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Synaptosomes; Tyrosine; Tyrosine 3-Monooxygenase | 1982 |
Effects of dopaminergic agents on monoamine levels and motor behaviour in planaria.
Topics: Animals; Apomorphine; Dopamine; Haloperidol; Levodopa; Motor Activity; Norepinephrine; Planarians; Serotonin; Turbellaria | 1983 |
Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Cells, Cultured; Dopamine; Endorphins; Female; Growth Hormone; Haloperidol; Humans; Levodopa; Male; Middle Aged; Norepinephrine; Pituitary Gland; Pituitary Neoplasms; Prolactin; Somatostatin; Thyrotropin-Releasing Hormone | 1984 |
Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Carbidopa; Catatonia; Diagnosis, Differential; Female; Haloperidol; Humans; Levodopa; Syndrome; Trihexyphenidyl | 1984 |
Effect of L-dopa on glutamate decarboxylase activity in the hypothalamic and amygdaloid nuclei.
Topics: Amygdala; Animals; Glutamate Decarboxylase; Haloperidol; Hypothalamus; Levodopa; Male; Pyridoxal Phosphate; Rats; Rats, Inbred Strains | 1984 |
Prolactin-releasing effect of zetidoline, a new neuroleptic agent, in the rat.
Topics: Animals; Antipsychotic Agents; Apomorphine; Chlorpromazine; Estrus; Female; Haloperidol; Imidazoles; Levodopa; Male; Pregnancy; Prolactin; Rats; Rats, Inbred Strains | 1984 |
Effects of drugs infused into a rat hypophysial portal vessel on prolactin and growth hormone release.
Topics: Animals; Chlorpromazine; Dopamine Antagonists; Growth Hormone; Haloperidol; Levodopa; Male; Pituitary Gland; Prolactin; Rats; Substance P | 1980 |
Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
Topics: Amantadine; Aminooxyacetic Acid; Amphetamine; Animals; Apomorphine; Baclofen; Dopamine; Electroshock; Female; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Hydroxybutyrates; Levodopa; Male; Mice; Phenobarbital; Phenytoin; Receptors, Neurotransmitter; Seizures | 1980 |
Beta-casomorphin inhibits thyrotropin secretion in rats.
Topics: Animals; Dose-Response Relationship, Drug; Endorphins; Haloperidol; Levodopa; Male; Rats; Rats, Inbred Strains; Serotonin; Thyrotropin; Thyrotropin-Releasing Hormone | 1984 |
Activation of dopamine synthesis in mesolimbic dopamine neurons by immobilization stress in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Haloperidol; Humans; Levodopa; Limbic System; Male; Neurons; Norepinephrine; Rats; Rats, Inbred Strains; Restraint, Physical; Stress, Psychological | 1984 |
[Attempted direct etiological treatment of Huntington's chorea. Case reports].
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Haloperidol; Humans; Huntington Disease; Levodopa; Middle Aged; Piperazines; Piribedil | 1980 |
Salivary secretion induced by L-DOPA in haloperidol-treated rats.
Topics: Animals; Carbidopa; Denervation; Haloperidol; Levodopa; Male; Norepinephrine; Phentolamine; Rats; Rats, Inbred Strains; Saliva; Submandibular Gland | 1984 |
Influence of dopamine, levodopa and apomorphine on maximal electroconvulsive seizure in the domestic fowl (Gallus domesticus).
Topics: Age Factors; Animals; Apomorphine; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Chickens; Dopamine; Drug Antagonism; Electroshock; Haloperidol; Levodopa; Male; Pimozide; Rats; Seizures; Species Specificity | 1984 |
L-dopa and apomorphine disrupt long- but not short-behavioural chains.
Topics: Agonistic Behavior; Animals; Apomorphine; Behavior, Animal; Carnivora; Ferrets; Haloperidol; Levodopa; Male; Receptors, Dopamine; Sexual Behavior, Animal; Territoriality | 1984 |
Age-related changes in rat brain dopaminergic receptors.
Topics: Age Factors; Animals; Brain; Cerebral Cortex; Corpus Striatum; Haloperidol; Hypothalamus; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1984 |
Neuropharmacological profile of Meige's disease: overview and a case report.
Topics: Aged; Baclofen; Benztropine; Clonazepam; Doxepin; Drug Therapy, Combination; Dystonia; Facial Muscles; Haloperidol; Humans; Levodopa; Male; Spasm | 1983 |
Time course of the litter removal-induced depletion in plasma prolactin levels of lactating rats. An immediate full blockade of the hormone release after separation.
Topics: alpha-Methyltyrosine; Animals; Female; Haloperidol; Lactation; Levodopa; Maternal Behavior; Methyltyrosines; Pimozide; Pregnancy; Prolactin; Rats; Rats, Inbred Strains; Time Factors | 1983 |
Pharmacologic manipulations of brain catecholamines and the behavior of Callithrix jacchus (marmoset).
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Callitrichinae; Catecholamines; Female; Haloperidol; Levodopa; Male; Methamphetamine; Methyltyrosines | 1981 |
Increase in mesolimbic electrical self-stimulation after chronic haloperidol: reversal by L-DOPA or lithium.
Topics: Animals; Carbidopa; Drug Antagonism; Electric Stimulation; Haloperidol; Levodopa; Lithium; Lithium Carbonate; Male; Rats; Self Stimulation; Tegmentum Mesencephali | 1981 |
The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
Topics: Animals; Apomorphine; Bromocriptine; Butyrophenones; Corpus Striatum; Dose-Response Relationship, Drug; Haloperidol; Humans; Levodopa; Male; Muridae; Receptors, Dopamine; Spiperone; Stereotyped Behavior | 1982 |
Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
Topics: Aminooxyacetic Acid; Animals; Apomorphine; Dopamine; gamma-Aminobutyric Acid; Haloperidol; Humans; Levodopa; Male; Picrotoxin; Rats; Stereotyped Behavior; Valproic Acid | 1982 |
Sensitive periods for the effect of haloperidol on development of striatal dopamine receptors.
Topics: alpha-Methyltyrosine; Animals; Corpus Striatum; Dopamine; Female; Gestational Age; Haloperidol; Levodopa; Methyltyrosines; Pregnancy; Rats; Receptors, Dopamine; Spiperone | 1983 |
Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig.
Topics: Animals; Apomorphine; Behavior, Animal; Carbidopa; Guinea Pigs; Haloperidol; Humans; Levodopa; Male; Stereotyped Behavior; Time Factors | 1982 |
Effects of Peripheral monoamines on the monosynaptic reflex neuronal activity of acute spinal cats.
Topics: Animals; Cats; Cordotomy; Dopamine; Dose-Response Relationship, Drug; Female; Haloperidol; Levodopa; Male; Motor Neurons; Norepinephrine; Pargyline; Phenoxybenzamine; Propranolol; Reflex, Monosynaptic | 1981 |
Receptor maturation in pathogenesis and treatment of Tourette syndrome.
Topics: Animals; Central Nervous System; Corpus Striatum; Dopamine; Haloperidol; Humans; Levodopa; Male; Rabbits; Receptors, Dopamine; Stereotyped Behavior; Tourette Syndrome | 1982 |
Tourette syndrome in oriental children: clinical and pathophysiological considerations.
Topics: Adolescent; Asian People; Child; Child, Preschool; Female; Haloperidol; Humans; Levodopa; Male; Pimozide; Posture; Sex Factors; Tic Disorders; Tourette Syndrome | 1982 |
Computerized EEG study on drug-induced extrapyramidalism in schizophrenic patients.
Topics: Adolescent; Amantadine; Brain; Computers; Electroencephalography; Female; Glycolates; Haloperidol; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Pyramidal Tracts; Reference Values; Schizophrenia; Thiophenes; Trihexyphenidyl | 1982 |
Value of monoamine metabolite determinations in CSF as an index of their concentrations in rat brain following various pharmacological manipulations.
Topics: 5-Hydroxytryptophan; Animals; Biogenic Amines; Brain Chemistry; Catecholamines; Chromatography, High Pressure Liquid; Haloperidol; Indoles; Levodopa; Male; Probenecid; Rats; Rats, Inbred Strains; Time Factors | 1982 |
The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain.
Topics: Animals; Brain; Haloperidol; Hydrazines; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1982 |
Brain catecholamine concentration during the first week of development in rats.
Topics: Animals; Animals, Newborn; Brain Chemistry; Dextroamphetamine; Dopamine; Female; Haloperidol; Levodopa; Male; Norepinephrine; Rats; Rats, Inbred Strains | 1982 |
The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig.
Topics: Animals; Apomorphine; Behavior, Animal; Carbidopa; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Humans; Levodopa; Male; Stereotyped Behavior; Time Factors | 1981 |
Studies on the mechanisms of L-dopa-induced salivary secretion.
Topics: Animals; Dopamine; Female; Haloperidol; Hexamethonium Compounds; Levodopa; Male; Norepinephrine; Rats; Salivation; Submandibular Gland; Sympathetic Nervous System | 1981 |
The effect of altered dopaminergic activity on food intake in the rat: evidence for an optimal level of dopaminergic activity for behavior.
Topics: Amphetamine; Amphetamines; Animals; Apomorphine; Brain; Cocaine; Dextroamphetamine; Dopamine; Feeding Behavior; Haloperidol; Levodopa; Methylphenidate; Rats; Spiperone | 1980 |
The catecholamine precursor L-3,4-dihydroxyphenylalanine inhibits both heat production and heat loss mechanisms in the rabbit.
Topics: Animals; Body Temperature Regulation; Haloperidol; Hydroxydopamines; Injections, Intraventricular; Levodopa; Male; Rabbits; Receptors, Adrenergic; Receptors, Dopamine | 1980 |
Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
Topics: 4-Butyrolactone; Amphetamine; Animals; Carbidopa; Corpus Striatum; Dopamine; Electrochemistry; Haloperidol; Levodopa; Male; Pargyline; Rats; Rats, Inbred Strains | 1981 |
The role of dopaminergic and serotonergic mechanisms in the development of swimming ability of young rats.
Topics: Age Factors; Amphetamine; Animals; Animals, Newborn; Apomorphine; Haloperidol; Hydroxydopamines; Levodopa; Methysergide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Swimming; Tryptophan | 1981 |
Accumulation of L-dopa in the median eminence: an index of tuberoinfundibular dopaminergic nerve activity.
Topics: Animals; Benzyl Alcohols; Corpus Striatum; Dopamine; Estradiol; Haloperidol; Hydrazines; Hypophysectomy; Hypothalamo-Hypophyseal System; Kinetics; Levodopa; Male; Median Eminence; Rats | 1980 |
[3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalen (ADTN). Regional distribution and in vivo binding after acute and chronic drug treatment.
Topics: Animals; Binding Sites; Brain; Caudate Nucleus; Haloperidol; Levodopa; Male; Naphthalenes; Naphthols; Rats; Subcellular Fractions; Tetrahydronaphthalenes | 1980 |
The effects of dopaminergic agents on the locomotor activity of rats after high doses of methylamphetamine.
Topics: Animals; Brain Chemistry; Dopamine; Drug Interactions; Haloperidol; Levodopa; Male; Methamphetamine; Motor Activity; Rats | 1980 |
A possible role for lysosomes in the inhibitory action of dopamine on prolactin release.
Topics: alpha-Methyltyrosine; Animals; Dopamine; Female; Haloperidol; Levodopa; Lysosomes; Methyltyrosines; Pituitary Gland; Prolactin; Rats | 1981 |
Role of prolactin and the renin-angiotensin system in mediating dopaminergic control of aldosterone secretion in the rat.
Topics: Aldosterone; Angiotensin II; Animals; Dopamine; Dopamine Antagonists; Haloperidol; Hypophysectomy; Levodopa; Male; Metoclopramide; Prolactin; Rats; Saralasin | 1981 |
Development of a melanin-based high-performance liquid chromatography stationary phase and its use in the study of drug-melanin binding interactions.
Topics: Antipsychotic Agents; Binding, Competitive; Chlorpromazine; Chromatography, Affinity; Chromatography, High Pressure Liquid; Haloperidol; Kinetics; Levodopa; Mathematics; Melanins; Phenothiazines; Promethazine | 1995 |
Higher environmental temperature-induced increase of body temperature: involvement of central opioidergic-GABAergic interaction.
Topics: Animals; Body Temperature; Body Temperature Regulation; Carbidopa; Dopamine Agents; Dopamine Antagonists; Endorphins; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Haloperidol; Hot Temperature; Levodopa; Male; Narcotic Antagonists; Parasympathetic Nervous System; Rats; Receptors, Opioid | 1995 |
The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Drug Interactions; Ergolines; Haloperidol; Levodopa; Male; Pilot Projects; Quinoxalines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1994 |
Chronic haloperidol: neural correlates of motor disorders in an invertebrate model.
Topics: Animals; Catecholamines; Disease Models, Animal; Dopamine; Fluorescence; Glyoxylates; Haloperidol; Histocytochemistry; Leeches; Levodopa; Locomotion; Movement; Movement Disorders; Neurotransmitter Agents | 1994 |
The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Benserazide; Benzophenones; Catalepsy; Catechol O-Methyltransferase Inhibitors; Drug Combinations; Drug Synergism; Haloperidol; Kinetics; Levodopa; Male; Mice; Mice, Inbred C57BL; Nitrophenols; Tolcapone; Tyrosine | 1994 |
KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.
Topics: Adenosine; Administration, Oral; Animals; Antihypertensive Agents; Benserazide; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Levodopa; Male; Mice; Phenethylamines; Purinergic Antagonists; Xanthines | 1994 |
3-O-methyldopa attenuates the effects of Madopar on the haloperidol-induced cataleptic behavior and the locomotor activity in the mouse.
Topics: Animals; Benserazide; Catalepsy; Drug Combinations; Haloperidol; Levodopa; Male; Mice; Motor Activity; Tyrosine | 1994 |
Influence of dopaminergic agonists/antagonists on fucose metabolism in the rat brain.
Topics: Animals; Brain; Cerebellum; Cerebral Cortex; Corpus Striatum; Dopamine; Fucose; Fucosyltransferases; Haloperidol; Levodopa; Male; Olfactory Pathways; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Wistar; Thalamus | 1993 |
Effects of spiradoline mesylate, a selective kappa-opioid-receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Brain; Brain Stem; Cerebral Cortex; Corpus Striatum; Dopamine; Haloperidol; Levodopa; Male; Methamphetamine; Mice; Morphine; Motor Activity; Pyrrolidines | 1993 |
Cocaine and dopaminergic actions in rat neostriatum.
Topics: Animals; Benzazepines; Cocaine; Depression, Chemical; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Electrophysiology; Haloperidol; Infusions, Intravenous; Levodopa; Male; Neostriatum; Neurons; Procaine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 1993 |
Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Bromocriptine; Corpus Striatum; Cycloheximide; Dopamine Antagonists; Haloperidol; Kinetics; Levodopa; Male; Mice; Pyridoxal Phosphate; Receptors, Dopamine; Reserpine; Sulpiride; Time Factors | 1993 |
Uridine reduces rotation induced by L-dopa and methamphetamine in 6-OHDA-treated rats.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Haloperidol; Levodopa; Male; Methamphetamine; Oxidopamine; Rats; Rats, Sprague-Dawley; Rotation; Uridine | 1995 |
[The prolactin and thyrotropic hormone content of the blood plasma in neostriatal dysfunction].
Topics: Basal Ganglia Diseases; Carbidopa; Dopamine Agonists; Dopamine Antagonists; Drug Combinations; Haloperidol; Humans; Immunoenzyme Techniques; Levodopa; Neostriatum; Prolactin; Thyrotropin; Time Factors | 1995 |
Drug-induced parkinsonism after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Female; Haloperidol; Humans; Levodopa; Parkinson Disease, Secondary; Transplantation, Homologous | 1996 |
The peripherally acting kappa-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity.
Topics: Acetamides; Analgesics, Opioid; Animals; Cerebellum; Dopamine Antagonists; Guinea Pigs; Haloperidol; Levodopa; Male; Nucleus Accumbens; Peripheral Nervous System; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa | 1995 |
[The effect on central dopaminergic structures of various hydrazides of phosphorylated carbonic acids and diaziridines].
Topics: Acetates; Animals; Apomorphine; Body Temperature; Catalepsy; Dopamine Agents; Drug Interactions; Haloperidol; Hydrazines; Levodopa; Mice; Stereotyped Behavior | 1996 |
[The morphochemical characteristics of the reaction of the motor structures of the brain to hyper- and hypofunction of the dopaminergic system].
Topics: Animals; Brain Chemistry; Caudate Nucleus; Dopamine Agents; Dopamine Antagonists; Haloperidol; Histocytochemistry; Levodopa; Motor Cortex; Neurons; Rats; Rats, Wistar; Receptors, Dopamine | 1996 |
Risk of syncope in the elderly and consumption of drugs: a case-control study.
Topics: Acepromazine; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Antipsychotic Agents; Case-Control Studies; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Fluoxetine; Haloperidol; Humans; Levodopa; Male; Matched-Pair Analysis; Pharmacoepidemiology; Risk; Syncope | 1997 |
The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Topics: Animals; Antiparkinson Agents; Benzazepines; Benzothiazoles; Body Temperature; Catalepsy; Clozapine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Injections, Subcutaneous; Levodopa; Male; Mice; Motor Activity; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Stereotyped Behavior; Sulpiride; Thiazoles | 1997 |
Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice.
Topics: Animals; Bromocriptine; Carbidopa; Catalepsy; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Kinetics; Levodopa; Male; Mice; Motor Activity | 1997 |
Tardive dyskinesia in dopa-responsive dystonia: a reappraisal of the dopamine hypothesis of tardive dyskinesia.
Topics: Adult; Anti-Dyskinesia Agents; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Dystonia; Family Health; Female; GTP Cyclohydrolase; Haloperidol; Humans; Levodopa; Male; Point Mutation | 1998 |
Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Brain Tissue Transplantation; Carrier Proteins; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fetal Tissue Transplantation; Functional Laterality; Haloperidol; Homovanillic Acid; Kinetics; Levodopa; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Microdialysis; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Rotation; Tritium; Tyrosine 3-Monooxygenase | 1998 |
Interaction between dopamine and glutamate in the sensorimotor cortex during conditioned placing reaction.
Topics: Amphetamine; Animals; Behavior, Animal; Cats; Conditioning, Classical; Dopamine; Glutamic Acid; Haloperidol; Levodopa; Male; Neocortex | 1998 |
[Dopamine-dependent pathology and trace processes].
Topics: Animals; Avoidance Learning; Dogs; Dopamine; Dopamine Agents; Dopamine Antagonists; Electric Stimulation; Evoked Potentials; Haloperidol; Levodopa; Motor Activity; Photic Stimulation | 1998 |
Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration.
Topics: Animals; Body Temperature; Brain; Dopamine; Free Radicals; Haloperidol; Levodopa; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurodegenerative Diseases; Paroxetine; Rats; Serotonin | 1999 |
GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist.
Topics: Animals; Antiparkinson Agents; Binding, Competitive; Catalepsy; Cyclopentanes; Drug Evaluation, Preclinical; Drug Synergism; Excitatory Amino Acid Antagonists; Glycine Agents; Haloperidol; Hypnotics and Sedatives; Levodopa; Male; Neuroprotective Agents; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reserpine | 1999 |
[Effect of MgS04, L-DOPA, and haloperidol on the delayed stereotyped behavior in rats caused by sensory-motor cortex hyperactivation].
Topics: Animals; Dopamine Agents; Electric Stimulation; Haloperidol; Levodopa; Magnesium Sulfate; Male; Motor Cortex; Periodicity; Posture; Rats; Reaction Time; Receptors, N-Methyl-D-Aspartate; Somatosensory Cortex; Stereotyped Behavior; Synaptic Transmission | 1999 |
Microdialysis studies on the action of tolcapone on pharmacologically-elevated extracellular dopamine levels in conscious rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzophenones; Carbidopa; Catechol O-Methyltransferase; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Interactions; Enzyme Inhibitors; Extracellular Space; Haloperidol; Homovanillic Acid; Levodopa; Male; Microdialysis; Nitrophenols; Piperazines; Rats; Rats, Wistar; Time Factors; Tolcapone; Visual Cortex | 1999 |
The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Catalepsy; Dextroamphetamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Fluphenazine; Haloperidol; Hyperkinesis; Levodopa; Locomotion; Male; Naphthalenes; Pyrrolidines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Tetrahydronaphthalenes | 1999 |
Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Haloperidol; Levodopa; Macaca mulatta; Male; Parkinson Disease, Secondary; Piperidines; Rats; Rats, Inbred F344; Reaction Time; Receptors, N-Methyl-D-Aspartate | 2000 |
The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Biogenic Monoamines; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Combinations; Enzyme Inhibitors; Haloperidol; Homovanillic Acid; Hydrazines; Levodopa; Male; Medial Forebrain Bundle; Oxidopamine; Rats; Rats, Wistar; Stereotyped Behavior; Tyrosine | 2001 |
SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Ankle Joint; Dopamine Agents; Dopamine Antagonists; Drug Combinations; Electromyography; Haloperidol; Levodopa; Male; Muscle Contraction; Muscle Rigidity; Muscle, Skeletal; Neostriatum; Neuroprotective Agents; Parkinsonian Disorders; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptors, Purinergic P1; Reserpine; Triazoles | 2001 |
Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation.
Topics: Animals; Benzazepines; Corpus Striatum; Dopamine; Dopamine D2 Receptor Antagonists; Female; Genes, fos; Haloperidol; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Dopamine D1; RNA, Messenger; Stereotyped Behavior | 2001 |
Lesioning the thalamus for dyskinesia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dyskinesias; Electrocoagulation; Haloperidol; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Reoperation; Retrospective Studies; Schizophrenia; Stereotaxic Techniques; Sulpiride; Torticollis; Treatment Outcome; Tremor; Ventral Thalamic Nuclei | 2001 |
Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Clozapine; Dopamine Agents; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Hippocampus; In Situ Hybridization; Levodopa; Male; Olanzapine; Pirenzepine; Rats; Rats, Wistar; RNA, Messenger | 2003 |
Viral encephalitis complicated by neuroleptic malignant syndrome in a 7-year-old girl.
Topics: Anticonvulsants; Carbidopa; Child; Dopamine Agents; Drug Therapy, Combination; Encephalitis, Viral; Epilepsy, Tonic-Clonic; Female; Haloperidol; Humans; Hypnotics and Sedatives; Levodopa; Neuroleptic Malignant Syndrome; Psychomotor Agitation | 2003 |
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.
Topics: 5-Hydroxytryptophan; Action Potentials; Animals; Antipsychotic Agents; Behavior, Animal; Binding Sites; Brain; Cell Count; Dioxanes; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Electric Stimulation; Electrochemistry; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Immunohistochemistry; In Vitro Techniques; Levodopa; Male; Microdialysis; Neurons; Piperazines; Proto-Oncogene Proteins c-fos; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Sulfur Isotopes; Time Factors; Tropanes | 2003 |
Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine.
Topics: Adult; Antipsychotic Agents; Brain; Clozapine; Dopamine Agents; Haloperidol; Humans; Least-Squares Analysis; Levodopa; Principal Component Analysis; Schizophrenia; Tomography, Emission-Computed | 2003 |
Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Topics: Age Factors; Animals; Behavior, Animal; Benzazepines; Carbidopa; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Gene Expression; Haloperidol; In Situ Hybridization; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Neurotensin; Pyrazoles; Quinolines; Receptors, Neurotensin; RNA, Messenger; Stereotyped Behavior; Time Factors; Tyrosine 3-Monooxygenase | 2004 |
A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Amantadine; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Dizocilpine Maleate; Dopamine Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Haloperidol; Idazoxan; Levodopa; Male; Motor Activity; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reserpine | 2005 |
Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Catalepsy; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesias; Functional Laterality; Haloperidol; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease; Pyridines; Quinolines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rotarod Performance Test; Thiazoles; Time Factors | 2006 |
Apomorphine-induced myocardial protection is due to antioxidant and not adrenergic/dopaminergic effects.
Topics: Adrenergic Agents; Animals; Antioxidants; Apomorphine; Dopamine Agents; Electrophoresis, Polyacrylamide Gel; Haloperidol; Heart; Hemodynamics; Immunoblotting; Levodopa; Male; Myocardial Reperfusion Injury; Propranolol; Rats; Rats, Sprague-Dawley | 2006 |
Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor.
Topics: Animals; Animals, Newborn; Antipsychotic Agents; Brain Chemistry; Catecholamines; Clozapine; Denervation; Dopamine; Dopamine Agents; Female; Haloperidol; Iron; Iron Overload; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Movement Disorders; MPTP Poisoning; Norepinephrine; Pregnancy; Psychotic Disorders; Signal Transduction; Weight Gain | 2007 |
Antagonism of haloperidol-induced swim impairment in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Caffeine; Catalepsy; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glutathione; Haloperidol; Levodopa; Male; Mice; Motor Activity; Parkinsonian Disorders; Posture; Superoxide Dismutase; Swimming | 2009 |
Effect of adenosine A(2A) receptor antagonists on L-DOPA-induced hydroxyl radical formation in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Area Under Curve; Benserazide; Catalepsy; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Homovanillic Acid; Hydroxyl Radical; Levodopa; Male; Microdialysis; Rats; Rats, Wistar; Time Factors; Triazines; Triazoles; Xanthines | 2009 |
Dopamine, time, and impulsivity in humans.
Topics: Adolescent; Adult; Brain; Brain Mapping; Corpus Striatum; Decision Making; Dopamine; Dopamine Agents; Dopamine Antagonists; Female; Haloperidol; Humans; Impulsive Behavior; Levodopa; Magnetic Resonance Imaging; Male; Reinforcement Schedule; Reward; Time Factors; Young Adult | 2010 |
Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors.
Topics: Animals; Catalepsy; Cocaine; Corpus Striatum; Dopamine Agents; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Female; Fluorescent Antibody Technique; Green Fluorescent Proteins; Haloperidol; Immunohistochemistry; Levodopa; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Motor Activity; Neuronal Plasticity; Neurons; Synaptic Potentials | 2010 |
Highly potent activity of (1R,2R,6S)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol in animal models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Cyclohexanols; Disease Models, Animal; Dopamine Antagonists; Drug Synergism; Haloperidol; Levodopa; Mice; Mice, Inbred C57BL; Molecular Conformation; Motor Activity; Neurotoxins; Parkinson Disease; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Neurotransmitter; Stereoisomerism | 2011 |
The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Brain; Calcium Signaling; Catalepsy; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Glutamic Acid; Haloperidol; HEK293 Cells; Humans; Levodopa; Male; Monoamine Oxidase; Motor Neuron Disease; Oxidopamine; Parkinson Disease; Picolinic Acids; Protein Binding; Psychomotor Performance; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reaction Time; Receptors, G-Protein-Coupled; Receptors, Metabotropic Glutamate; Substantia Nigra; Thallium; Transfection; Triazoles; Tyrosine 3-Monooxygenase | 2012 |
Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.
Topics: Allosteric Regulation; Aminobutyrates; Anilides; Animals; Catalepsy; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesia, Drug-Induced; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Haloperidol; Levodopa; Male; Oxidopamine; Parkinson Disease; Phosphinic Acids; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Synaptic Transmission | 2013 |
Histamine- and haloperidol-induced catalepsy in aged mice: differential responsiveness to L-DOPA.
Topics: Aging; Animals; Antiparkinson Agents; Catalepsy; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Mice, Inbred BALB C; Parkinson Disease; Time Factors | 2012 |
Striatal interaction among dopamine, glutamate and ascorbate.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Ascorbic Acid; Basal Ganglia Diseases; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agents; Dopamine Antagonists; Electrochemistry; Fluorometry; Glutamic Acid; Haloperidol; Levodopa; Male; Microdialysis; Neostriatum; Rats; Rats, Sprague-Dawley | 2012 |
Effects of dopaminergic system activation on feeding behavior and growth performance of the sea bass (Dicentrarchus labrax): a self-feeding approach.
Topics: Animal Feed; Animals; Bass; Biogenic Monoamines; Cloning, Molecular; Corticotropin-Releasing Hormone; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Feeding Behavior; Female; Gene Expression; Growth; Haloperidol; Levodopa; Male; Neuropeptides | 2013 |
A2A receptor antagonists do not induce dyskinesias in drug-naive or L-dopa sensitized rats.
Topics: Adenosine A2 Receptor Antagonists; Adrenergic Agents; Analysis of Variance; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Catalepsy; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Time Factors | 2013 |
Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons.
Topics: Animals; Diphtheria Toxin; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Gait; Haloperidol; Levodopa; Mesencephalon; Mice; Mice, Transgenic; Mutation | 2013 |
Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report.
Topics: Adolescent; Amantadine; Carbidopa; Cerebral Palsy; Cognition Disorders; Dopamine Agonists; Dopamine Antagonists; Drug Combinations; Haloperidol; Humans; Levodopa; Male; Psychomotor Disorders | 2013 |
The role of dopamine in motor flexibility.
Topics: Adult; Anticipation, Psychological; Dopamine; Dopamine Agents; Double-Blind Method; Female; Haloperidol; Humans; Levodopa; Male; Probability; Psychomotor Performance; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 2015 |
Effects of dopamine uptake inhibitor MRZ-9547 in animal models of Parkinson's disease.
Topics: Acetamides; Animals; Brain; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Levodopa; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pyrrolidinones; Rats, Sprague-Dawley | 2015 |
Involvement of cholinergic system in hyperactivity in dopamine-deficient mice.
Topics: Acetylcholine; Akathisia, Drug-Induced; Animals; Anti-Dyskinesia Agents; Antipsychotic Agents; Central Nervous System Stimulants; Choline O-Acetyltransferase; Clozapine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Extracellular Space; Haloperidol; Levodopa; Locomotion; Mice, Inbred C57BL; Piperazines; Psychomotor Agitation; Thiazoles | 2015 |
Alteration in the expression of exon IIC transcripts of brain-derived neurotrophic factor gene by simvastatin [correction of simvastain] in chronic mild stress in mice: a possible link with dopaminergic pathway.
Topics: Animals; Brain-Derived Neurotrophic Factor; Bromocriptine; Chronic Disease; Dopamine; Dopamine Agents; Eating; Exons; Haloperidol; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Levodopa; Lipid Metabolism; Male; Mice; Signal Transduction; Simvastatin; Stress, Psychological; Sucrose; Transcription, Genetic | 2014 |
Reversal learning and dopamine: a bayesian perspective.
Topics: Algorithms; Animals; Bayes Theorem; Choice Behavior; Conditioning, Operant; Dopamine; Dopamine Agents; Dopamine Antagonists; Female; Haloperidol; Levodopa; Macaca mulatta; Male; Reversal Learning | 2015 |
Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.
Topics: Aminobutyrates; Animals; Antiparkinson Agents; Catalepsy; Dyskinesia, Drug-Induced; Excitatory Amino Acid Agents; Haloperidol; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Phosphinic Acids; Picolinic Acids; Random Allocation; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate | 2015 |
NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Brain; Catalepsy; Disease Models, Animal; Drug Interactions; Dyskinesia, Drug-Induced; Female; Haloperidol; Levodopa; Movement; Neurotransmitter Agents; Oxidopamine; Piperidines; Psychomotor Performance; Pyridines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT1 Receptor Agonists; Serotonin Syndrome; Swimming; Vocalization, Animal | 2015 |
Effects of acute dopaminergic and serotonergic manipulations in the ACI paradigm depend on the basal valence of cognitive judgement bias in rats.
Topics: Animals; Citalopram; Cognition; Cues; Discrimination, Psychological; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Haloperidol; Judgment; Levodopa; Male; Optimism; Pessimism; Psychological Tests; Punishment; Rats, Sprague-Dawley; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin | 2017 |
Hypothalamic dopamine is required for salsolinol-induced prolactin secretion in goats.
Topics: Animals; Carbidopa; Dopamine; Dopamine D2 Receptor Antagonists; Drug Combinations; Female; Goats; Haloperidol; Hypothalamus; Injections, Intravenous; Isoquinolines; Levodopa; Prolactin; Thyrotropin-Releasing Hormone | 2017 |
Dopaminergic tone does not influence pain levels during placebo interventions in patients with chronic neuropathic pain.
Topics: Adult; Aged; Anesthetics, Local; Carbidopa; Chronic Pain; Dopamine; Dopamine Agents; Drug Combinations; Female; Haloperidol; Humans; Levodopa; Lidocaine; Male; Middle Aged; Motivation; Neuralgia; Placebo Effect; Placebos; Psychological Tests; Retrospective Studies; Suggestion | 2018 |
Haloperidol-induced parkinsonism is attenuated by varenicline in mice.
Topics: Animals; Catalepsy; Disease Models, Animal; Dopamine; Female; Haloperidol; Levodopa; Male; Mice; Neurons; Parkinsonian Disorders; Varenicline | 2018 |
Coumarin analogue 3-methyl-7H-furo[3,2-g] chromen-7-one as a possible antiparkinsonian agent
Topics: Animals; Antiparkinson Agents; Carbidopa; Catalepsy; Coumarins; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Locomotion; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Reserpine | 2019 |
Experimental study of antiparkinsonian action of the harmine hydrochloride original compound.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Catalepsy; Haloperidol; Harmine; Levodopa; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Rats | 2019 |
Dopaminergic modulation of the exploration/exploitation trade-off in human decision-making.
Topics: Adult; Bayes Theorem; Decision Making; Dopamine; Haloperidol; Humans; Levodopa; Machine Learning; Male; Reward; Stochastic Processes; Uncertainty; Young Adult | 2020 |
Phytoconstituents of Datura metel extract improved motor coordination in haloperidol-induced cataleptic mice: Dual-target molecular docking and behavioural studies.
Topics: alpha-Synuclein; Animals; Antioxidants; Antiparkinson Agents; Atropine Derivatives; Carbidopa; Cholinergic Antagonists; Datura metel; Dopa Decarboxylase; Haloperidol; Levodopa; Methanol; Mice; Molecular Docking Simulation; Parkinson Disease; Phytochemicals; Plant Extracts; Scopolamine | 2023 |
Dopamine increases risky choice while D2 blockade shortens decision time.
Topics: Decision Making; Dopamine; Dopamine Agents; Haloperidol; Humans; Levodopa; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2022 |
Dopamine regulates decision thresholds in human reinforcement learning in males.
Topics: Dopamine; Haloperidol; Humans; Levodopa; Male; Men; Plastic Surgery Procedures | 2023 |